POLYCOM INC, 10-Q filed on 5/1/2014
Quarterly Report
Document and Entity Information
3 Months Ended
Mar. 31, 2014
Apr. 25, 2014
Document Information [Line Items]
 
 
Document Type
10-Q 
 
Amendment Flag
false 
 
Document Period End Date
Mar. 31, 2014 
 
Document Fiscal Year Focus
2014 
 
Document Fiscal Period Focus
Q1 
 
Trading Symbol
PLCM 
 
Entity Registrant Name
POLYCOM INC 
 
Entity Central Index Key
0001010552 
 
Current Fiscal Year End Date
--12-31 
 
Entity Filer Category
Large Accelerated Filer 
 
Entity Common Stock, Shares Outstanding
 
138,149,319 
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Current assets
 
 
Cash and cash equivalents
$ 380,214 
$ 392,629 
Short-term investments
149,890 
134,684 
Trade receivables, net of allowance for doubtful accounts of $2,805 and $2,827 at March 31, 2014 and December 31, 2013, respectively
184,239 
183,369 
Inventories
103,280 
103,309 
Deferred taxes
37,079 
37,085 
Prepaid expenses and other current assets
58,982 
50,352 
Total current assets
913,684 
901,428 
Property and equipment, net
109,146 
115,157 
Long-term investments
65,835 
56,372 
Goodwill
559,234 
559,460 
Purchased intangibles, net
34,106 
37,458 
Deferred taxes
44,425 
51,398 
Other assets
27,654 
27,757 
Total assets
1,754,084 
1,749,030 
Current liabilities
 
 
Accounts payable
92,616 
84,640 
Accrued payroll and related liabilities
32,051 
40,162 
Taxes payable
3,797 
5,389 
Deferred revenue
172,703 
172,408 
Current portion of long-term debt
6,250 
6,250 
Other accrued liabilities
76,841 
77,744 
Total current liabilities
384,258 
386,593 
Non-current liabilities
 
 
Long-term deferred revenue
86,078 
87,467 
Taxes payable
12,553 
12,419 
Deferred taxes
150 
149 
Long-term debt
240,625 
242,188 
Other non-current liabilities
50,204 
43,849 
Total non-current liabilities
389,610 
386,072 
Total liabilities
773,868 
772,665 
Stockholders' equity
 
 
Common stock, $0.0005 par value; Authorized: 350,000,000 shares; Issued and outstanding: 138,148,354 shares at March 31, 2014 and 135,159,966 shares at December 31, 2013
68 
68 
Additional paid-in capital
1,113,080 
1,104,273 
Accumulated deficit
(136,338)
(132,348)
Accumulated other comprehensive income
3,406 
4,372 
Total stockholders' equity
980,216 
976,365 
Total liabilities and stockholders' equity
$ 1,754,084 
$ 1,749,030 
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Trade receivables, allowance for doubtful accounts
$ 2,805 
$ 2,827 
Common stock, par value
$ 0.0005 
$ 0.0005 
Common stock, shares authorized
350,000,000 
350,000,000 
Common stock, shares issued
138,148,354 
135,159,966 
Common stock, shares outstanding
138,148,354 
135,159,966 
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:
 
 
Product revenues
$ 231,509 
$ 246,129 
Service revenues
97,015 
92,623 
Total revenues
328,524 
338,752 
Cost of revenues:
 
 
Cost of product revenues
97,636 
101,878 
Cost of service revenues
38,903 
37,777 
Total cost of revenues
136,539 
139,655 
Gross profit
191,985 
199,097 
Operating expenses:
 
 
Sales and marketing
93,968 
108,715 
Research and development
48,147 
55,935 
General and administrative
23,793 
23,694 
Amortization of purchased intangibles
2,492 
2,502 
Restructuring costs
30,343 
5,423 
Transaction-related costs
156 
3,323 
Total operating expenses
198,899 
199,592 
Operating loss
(6,914)
(495)
Interest and other income (expense), net:
 
 
Interest expense
(1,474)
(407)
Other income (expense)
779 
(352)
Interest and other income (expense), net
(695)
(759)
Loss from continuing operations before benefit from income taxes
(7,609)
(1,254)
Benefit from income taxes
(3,618)
(3,371)
Net income (loss) from continuing operations
(3,991)
2,117 
Gain from sale of discontinued operations, net of taxes
 
459 
Net income (loss)
$ (3,991)
$ 2,576 
Basic net income (loss) per share:
 
 
Net income (loss) per share from continuing operations
$ (0.03)
$ 0.01 
Gain per share from sale of discontinued operations, net of taxes
   
   
Basic net income (loss) per share
$ (0.03)
$ 0.01 
Diluted net income (loss) per share:
 
 
Net income (loss) per share from continuing operations
$ (0.03)
$ 0.01 
Gain per share from sale of discontinued operations, net of taxes
   
   
Diluted net income (loss) per share
$ (0.03)
$ 0.01 
Number of shares used in computation of net income (loss) per share
 
 
Basic
136,795 
176,079 
Diluted
136,795 
179,140 
Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Net income (loss)
$ (3,991)
$ 2,576 
Other comprehensive income (loss), net of tax:
 
 
Foreign currency translation adjustments
(1,203)
64 
Unrealized gains/losses on investments:
 
 
Unrealized holding gains (losses) arising during the period
(7)
(12)
Net gains/losses reclassified into earnings
(1)
66 
Net unrealized gains (losses) on investments
(8)
54 
Unrealized gains/losses on hedging securities:
 
 
Unrealized hedge gains (losses) arising during the period
(421)
2,957 
Net unrealized (losses) on hedging securities
245 
2,243 
Other comprehensive income (loss)
(966)
2,361 
Comprehensive income (loss)
(4,957)
4,937 
Product revenues
 
 
Unrealized gains/losses on hedging securities:
 
 
Net gains/losses reclassified into earnings for hedges
2,865 
(627)
Expense
 
 
Unrealized gains/losses on hedging securities:
 
 
Net gains/losses reclassified into earnings for hedges
$ (2,199)
$ (87)
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:
 
 
Net income (loss)
$ (3,991)
$ 2,576 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
Depreciation and amortization
14,533 
16,430 
Amortization of purchased intangibles
3,352 
3,768 
Amortization of software development costs
288 
 
Amortization of debt issuance costs
134 
   
Amortization of discounts and premiums on investments, net
442 
386 
Write-down of excess and obsolete inventories
1,781 
2,934 
Stock-based compensation expense
5,647 
17,771 
Excess tax benefits from stock-based compensation expense
(1,695)
(155)
Loss on disposal of property and equipment
3,685 
1,206 
Net gain on sale of discontinued operations
 
(459)
Changes in assets and liabilities, net of effects of acquisitions:
 
 
Trade receivables
(870)
17,179 
Inventories
(1,752)
(525)
Deferred taxes
(1,762)
1,994 
Prepaid expenses and other assets
(8,623)
(4,530)
Accounts payable
6,750 
7,857 
Taxes payable
4,936 
(1,681)
Other accrued liabilities and deferred revenue
(3,761)
(15,351)
Net cash provided by operating activities
19,094 
49,400 
Cash flows from investing activities:
 
 
Purchases of property and equipment
(10,929)
(12,757)
Capitalized software development costs for products to be sold
(1,073)
 
Purchases of investments
(90,663)
(55,754)
Proceeds from sales of investments
30,114 
9,227 
Proceeds from maturities of investments
35,430 
68,136 
Net cash received from sale of discontinued operations
 
556 
Net cash paid in purchase acquisitions
 
(8,350)
Net cash provided by (used in) investing activities
(37,121)
1,058 
Cash flows from financing activities:
 
 
Proceeds from issuance of common stock under employee option and stock purchase plans
13,295 
13,206 
Payments on debt
(1,562)
 
Purchase and retirement of common stock
(7,816)
(38,041)
Excess tax benefits from stock-based compensation expense
1,695 
155 
Net cash provided by (used in) financing activities
5,612 
(24,680)
Net increase (decrease) in cash and cash equivalents
(12,415)
25,778 
Cash and cash equivalents, beginning of period
392,629 
477,073 
Cash and cash equivalents, end of period
$ 380,214 
$ 502,851 
Basis of Presentation
Basis of Presentation

1. BASIS OF PRESENTATION

The accompanying unaudited financial statements, consisting of the condensed consolidated balance sheets as of March 31, 2014, the condensed consolidated statements of operations for the three months ended March 31, 2014 and 2013, the condensed consolidated statements of comprehensive income for the three months ended March 31, 2014 and 2013, and the condensed consolidated statements of cash flows for the three months ended March 31, 2014 and 2013, have been prepared in accordance with accounting principles generally accepted in the United States of America in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. In addition, the condensed consolidated balance sheet at December 31, 2013 has been derived from the audited consolidated financial statements as of that date. Accordingly, these condensed consolidated financial statements do not include all of the information and footnotes typically found in the audited consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K of Polycom, Inc. and its subsidiaries (the “Company”). In the opinion of management, the accompanying unaudited financial statements have been prepared on a basis consistent with the Company’s December 31, 2013 audited financial statements and all adjustments (primarily consisting of normal recurring adjustments) considered necessary for a fair statement have been included. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates and operating results for the three months ended March 31, 2014 and are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

Revision of Prior Period Financial Statements

During the three months ended December 31, 2013, the Company discovered an error that impacted the Company’s previously issued interim and annual consolidated statements of cash flows. The error was related to the net amortization of discounts and premiums on investments not being properly reported, which resulted in understated cash flows provided by operating activities and understated or overstated cash provided by or used in investing activities in the first three quarters of 2013 and full fiscal years 2012 and 2011.

In evaluating whether the Company’s previously issued condensed consolidated statements of cash flows were materially misstated, the Company considered the guidance in ASC Topic 250, Accounting Changes and Error Corrections, ASC Topic 250-10-S99-1, Assessing Materiality, and ASC Topic 250-10-S99-2, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements. The Company concluded that this error was not material to any of the prior reporting periods, and therefore, amendments of previously filed reports were not required. However, the consolidated statements of cash flow correction would impact comparisons to prior periods. As such, the revision for the correction is reflected in the financial information of the applicable prior periods and will be reflected in future filings containing such financial information.

The following table sets forth a summary of the revision to the condensed consolidated statement of cash flows for the following period (in thousands):

 

 

Three Months Ended March 31, 2013

 

 

As Previously

Reported

 

 

Adjustment

 

 

As Revised

 

Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

 

Amortization of discounts and premiums on investments, net

$

 

 

$

386

 

 

$

386

 

Net cash provided by operating activities

$

49,014

 

 

$

386

 

 

$

49,400

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

$

(55,368

)

 

$

(386

)

 

$

(55,754

)

Net cash provided by investing activities

$

1,444

 

 

$

(386

)

 

$

1,058

 

 

 

Summary of Significant Accounting Policies
Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Company’s significant accounting policies were described in Note 1 to the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (the “2013 Form 10-K”). With the exception of the accounting standards update discussed below, there have been no significant changes to these policies and no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2014, that are of significance or potential significance to the Company.

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update which clarifies that an unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations where a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The guidance is effective prospectively for reporting periods beginning after December 15, 2013. The Company adopted the guidance in the three months ended March 31, 2014, and such adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Discontinued Operations
Discontinued Operations

3. DISCONTINUED OPERATIONS

On December 4, 2012, the Company completed the disposition of the net assets of its enterprise wireless voice solutions (“EWS”) business to Mobile Devices Holdings, LLC, a Delaware limited liability corporation. The Company received cash consideration of approximately $50.7 million, resulting in a gain on sale of the discontinued operations, net of taxes, of $35.4 million, as reflected in its consolidated financial statements for the year ended December 31, 2012. In the three months ended March 31, 2013, the Company recorded an additional gain on sale of discontinued operations, net of taxes, of approximately $0.5 million as a result of the final net working capital adjustment in accordance with the Purchase Agreement. Additional cash consideration of up to $37.5 million is payable to Polycom over the next three years subject to certain conditions, including meeting certain agreed-upon EBITDA-based milestones for the fiscal years ending December 31, 2014, 2015 and 2016.  These conditions were not met for the fiscal year ended December 31, 2013. Such additional cash consideration will be accounted for as a gain on sale of discontinued operations, net of taxes, when it is realized or realizable. For the three months ended March 31, 2014, there was no realized gain on sale of discontinued operations.

Business Combinations
Business Combinations

4. BUSINESS COMBINATIONS

On March 1, 2013 the Company completed its acquisition of certain assets of Sentri, Inc. (“Sentri”), a privately-held services company with expertise in Microsoft technologies, for approximately $8.0 million in cash, net of approximately $0.4 million cash released from an escrow account as a result of a net working capital adjustment. The total purchase price was allocated to the net tangible and intangible assets based upon their fair values at March 1, 2013 with the excess amount recorded as goodwill. The goodwill is primarily attributable to the expertise of former Sentri employees in Microsoft technologies and expected synergies from the combined company. The Company has included the financial results of Sentri in its condensed consolidated financial statements from the date of acquisition. Pro forma and actual results of operations of the acquisition were not material to the Company’s condensed consolidated financial statements.

 

Accounts Receivable Financing
Accounts Receivable Financing

5. ACCOUNTS RECEIVABLE FINANCING

In 2012, the Company launched a customer financing program and entered into a financing agreement (the “Financing Agreement”) with an unrelated third party financing company. The program offers channel partners, distributors, and resellers direct or indirect financing on their purchases of the Company’s products and services. Pursuant to the terms of the Financing Agreement, the Company transfers accounts receivable from these customers, without recourse, to the financing company. In return, the Company agrees to pay the financing company a fee based on a pre-defined percentage of the transaction amount financed. If the transaction meets the applicable criteria under ASC 860 and is accounted for as a sale of financial assets, the accounts receivable are excluded from the balance sheet upon the third party financing company’s payment remittance to the Company. In certain legal jurisdictions, the arrangement fees that involve maintenance services or products bundled with maintenance at one price do not qualify as a sale of financial assets in accordance with the authoritative guidance. Accordingly, accounts receivable related to these arrangements are accounted for as a secured borrowing in accordance with ASC 860, and the Company records a liability for any cash received, while maintaining the associated accounts receivable balance until the end-customer remits payment to the third-party financing company.

In the three months ended March 31, 2014, total transactions entered pursuant to the terms of the Financing Agreement were approximately $32.0 million, of which $31.1 million was related to the sale of the financial assets arrangement. In the three months ended March 31, 2013, total transactions entered were approximately $24.9 million, of which $22.3 million was related to the sale of the financial assets arrangement. The financing of these receivables accelerated the collection of the Company’s cash and reduced its credit exposure. The amount due from the financing company as of March 31, 2014 and December 31, 2013 was approximately $19.7 million and $22.9 million, respectively, of which $19.2 million and $21.6 million, respectively, was related to the accounts receivable sold, and is included in “Trade receivables” in the Company’s condensed consolidated balance sheets. Fees incurred pursuant to the Financing Agreement were approximately $0.5 million and $0.3 million for the three months ended March 31, 2014 and 2013, respectively. Those fees were recorded as reductions to revenues.

Goodwill, Purchased Intangibles, and Software Development Costs
Goodwill, Purchased Intangibles, and Software Development Costs

6. GOODWILL, PURCHASED INTANGIBLES, AND SOFTWARE DEVELOPMENT COSTS

Goodwill

The following table presents the changes to the Company’s goodwill by segment during the three months ended March 31, 2014 (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

Balance at December 31, 2013

$

308,159

 

 

$

101,882

 

 

$

149,419

 

 

$

559,460

 

Foreign currency translation

 

 

 

 

 

 

 

(226

)

 

 

(226

)

Balance at March 31, 2014

$

308,159

 

 

$

101,882

 

 

$

149,193

 

 

$

559,234

 

Purchased Intangible Assets and Software Development Costs

The following table presents details of the Company’s total purchased intangible assets and capitalized software development costs as of the following periods (in thousands):

 

 

March 31, 2014

 

 

December 31, 2013

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

Core and developed technology

$

81,178

 

 

$

(77,793

)

 

$

3,385

 

 

$

81,178

 

 

$

(76,952

)

 

$

4,226

 

Customer and partner relationships

 

79,525

 

 

 

(51,248

)

 

 

28,277

 

 

 

79,525

 

 

 

(48,941

)

 

 

30,584

 

Non-compete agreements

 

1,800

 

 

 

(650

)

 

 

1,150

 

 

 

1,800

 

 

 

(500

)

 

 

1,300

 

Trade name

 

3,400

 

 

 

(3,124

)

 

 

276

 

 

 

3,400

 

 

 

(3,089

)

 

 

311

 

Other

 

4,462

 

 

 

(4,362

)

 

 

100

 

 

 

4,462

 

 

 

(4,343

)

 

 

119

 

Finite-lived intangible assets

 

170,365

 

 

 

(137,177

)

 

 

33,188

 

 

 

170,365

 

 

 

(133,825

)

 

 

36,540

 

Indefinite-lived trade name

 

918

 

 

 

 

 

 

918

 

 

 

918

 

 

 

 

 

 

918

 

Total acquired intangible assets

$

171,283

 

 

$

(137,177

)

 

$

34,106

 

 

$

171,283

 

 

$

(133,825

)

 

$

37,458

 

Software development costs for products to be sold

$

3,474

 

 

$

(484

)

 

$

2,990

 

 

$

2,365

 

 

$

(196

)

 

$

2,169

 

 

Purchased intangibles include a purchased trade name of $0.9 million with an indefinite life as the Company expects to generate cash flows related to this asset indefinitely. Consequently, this trade name is not amortized but is reviewed for impairment annually or sooner when indicators of potential impairment exist.

The following table summarizes the amortization expenses recorded in the following periods (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Amortization of purchased intangibles in revenues

$

19

 

 

$

18

 

Amortization of purchased intangibles in cost of product revenues

 

841

 

 

 

1,248

 

Amortization of purchased intangibles in operating expenses

 

2,492

 

 

 

2,502

 

Total amortization expenses of purchased intangibles

$

3,352

 

 

$

3,768

 

 

Amortization of purchased intangibles is not allocated to the Company’s segments.

The estimated future amortization expense as of March 31, 2014 is as follows (in thousands):

 

Year ending December 31,

 

Amount

 

Remainder of 2014

 

$

9,539

 

2015

 

 

10,495

 

2016

 

 

8,484

 

2017

 

 

4,670

 

2018

 

 

 

Total

 

$

33,188

 

 

In the three months ended March 31, 2014, the Company capitalized approximately $1.1 million of software development costs for internally developed software products to be marketed and sold to customers after the point that technological feasibility has been reached and before the products are available for general release. There were no such costs capitalized in the three months ended March 31, 2013 as the development costs qualifying for capitalization were insignificant. The capitalized costs are being amortized over the estimated product useful life, generally three years, beginning when the products are available for general release. Management expects that the capitalized software development costs are recoverable from future gross profits generated by these products and services.

 

Restructuring Costs
Restructuring Costs

7. RESTRUCTURING COSTS

The Company recorded restructuring costs of $30.3 million and $5.4 million during the three months ended March 31, 2014 and 2013, respectively. Pursuant to the announcement in February 2014, management took certain actions designed to better align expenses to the Company’s revenue and gross margin profile and position the Company for improved operating performance. These actions included the elimination of approximately six percent of the global workforce and reduction or elimination of certain leased facilities. The Company has recorded approximately $29.9 million in restructuring costs as of March 31, 2014 in connection with these actions and expects to record remaining charges (primarily related to certain leased facilities) through the third quarter of 2014.

The following table summarizes the changes in the Company’s restructuring reserves during the three months ended March 31, 2014 (in thousands):

 

 

Severance/Other

 

 

Facilities

 

 

Total

 

Balance at December 31, 2013

$

1,143

 

 

$

33,786

 

 

$

34,929

 

Additions to the reserve

 

10,557

 

 

 

19,786

 

 

 

30,343

 

Non-cash write-offs

 

 

 

 

(3,359

)

 

 

(3,359

)

Cash payments and other usage

 

(8,264

)

 

 

(3,468

)

 

 

(11,732

)

Balance at March 31, 2014

$

3,436

 

 

$

46,745

 

 

$

50,181

 

As of March 31, 2014, the restructuring reserve is primarily comprised of facilities-related liabilities. The Company calculated the fair value of its facilities-related liabilities based on the discounted future lease payments less sublease assumptions. This fair value measurement is classified as a Level 3 measurement under ASC 820. The key assumptions used in the valuation model include discount rates, cash flow projections, and estimated sublease income. These assumptions involve significant judgment, are based on management’s estimate of current and forecasted market conditions and are sensitive and susceptible to change.

Balance Sheet Details
Balance Sheet Details

8. BALANCE SHEET DETAILS

Inventories are valued at the lower of cost or market with cost computed on a first-in, first-out (“FIFO”) basis. Consideration is given to obsolescence, excessive levels, deterioration and other factors in evaluating net realizable value.

Inventories consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Raw materials

$

3,210

 

 

$

2,740

 

Work in process

 

1,002

 

 

 

840

 

Finished goods

 

99,068

 

 

 

99,729

 

 

$

103,280

 

 

$

103,309

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Non-trade receivables

$

9,245

 

 

$

9,251

 

Prepaid expenses

 

40,422

 

 

 

31,164

 

Derivative assets

 

5,448

 

 

 

6,748

 

Other current assets

 

3,867

 

 

 

3,189

 

 

$

58,982

 

 

$

50,352

 

Deferred revenues consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Short-term:

 

 

 

 

 

 

 

Service

$

171,041

 

 

$

170,701

 

Product

 

112

 

 

 

307

 

License

 

1,550

 

 

 

1,400

 

 

$

172,703

 

 

$

172,408

 

Long-term:

 

 

 

 

 

 

 

Service

$

82,003

 

 

$

83,092

 

Product

 

18

 

 

 

 

License

 

4,057

 

 

 

4,375

 

 

$

86,078

 

 

$

87,467

 

Other accrued liabilities consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Accrued expenses

$

20,658

 

 

$

22,515

 

Accrued co-op expenses

 

4,159

 

 

 

4,629

 

Restructuring reserves

 

20,060

 

 

 

11,238

 

Warranty obligations

 

10,006

 

 

 

9,475

 

Derivative liabilities

 

6,172

 

 

 

6,780

 

Employee stock purchase plan withholdings

 

4,132

 

 

 

10,883

 

Other accrued liabilities

 

11,654

 

 

 

12,224

 

 

$

76,841

 

 

$

77,744

 

 

Guarantees
Guarantees

9. GUARANTEES

Warranty

Changes in the warranty obligation which is included as a component of “Other accrued liabilities” on the condensed consolidated balance sheets are as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Balance at beginning of period

$

9,475

 

 

$

10,475

 

Accruals for warranties issued during the period

 

4,165

 

 

 

3,619

 

Actual charges against warranty reserve during the period

 

(3,634

)

 

 

(4,379

)

Balance at end of period

$

10,006

 

 

$

9,715

 

Deferred Services Revenue

Changes in the deferred services revenue are as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Balance at beginning of period

$

253,793

 

 

$

241,773

 

Additions to deferred services revenue

 

85,894

 

 

 

87,752

 

Amortization of deferred services revenue

 

(86,643

)

 

 

(83,506

)

Balance at end of period

$

253,044

 

 

$

246,019

 

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, the Company has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was serving, at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification obligations is unlimited; however, the Company has a director and officer insurance policy that mitigates the Company’s exposure and enables the Company to recover a portion of any future amounts paid. As a result of the Company’s insurance policy coverage, the Company believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in the Company’s industry, as provided for in local law in the U.S. and other jurisdictions, the Company’s standard contracts provide remedies to its customers, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of its products. From time to time, the Company indemnifies customers against combinations of loss, expense, or liability arising from various trigger events related to the sale and the use of its products and services. In addition, from time to time the Company also provides protection to customers against claims related to undiscovered liabilities, additional product liability or environmental obligations.

Debt
Debt

10. DEBT

On September 13, 2013, the Company entered into a Credit Agreement (the “Credit Agreement”) among the Company, certain of its subsidiaries from time to time party thereto as guarantors, the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as Administrative Agent and Collateral Agent. The Credit Agreement provides for a $250.0 million term loan (the “Term Loan”) maturing on September 13, 2018 (the “Maturity Date”) and bears interest at the Company’s option at either a base rate plus a spread of 0.50% to 1.00%, or a reserve adjusted LIBOR rate plus a spread of 1.50% to 2.00% based on the Company’s consolidated leverage ratio for the preceding four fiscal quarters.

The Company entered into the Credit Agreement in conjunction with and for purposes of funding purchases of the Company’s common stock pursuant to a $250.0 million modified “Dutch Auction” self-tender offer announced in September 2013. See Note 13 for further details. Interest is due and payable in arrears quarterly for loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of loans bearing interest at the reserve adjusted LIBOR rate. The Term Loan is payable in quarterly installments of principal equal to $1.6 million which began on December 31, 2013, with the remaining outstanding principal amount of the Term Loan being due and payable on the Maturity Date. The Company may prepay the Term Loan, in whole or in part, at any time without premium or penalty. Amounts repaid or prepaid may not be reborrowed. The Term Loan is secured by substantially all the assets of certain domestic subsidiaries of the Company, subject to certain exceptions and limitations. The Company is also obligated to pay other customary closing fees, arrangement fees, and administration fees for a credit facility of this size and type. Total debt issuance costs incurred on the Term Loan were approximately $2.7 million and were recorded in “Prepaid expenses and other current assets” and “Other assets” on the condensed consolidated balance sheet and are being amortized over the life of the Term Loan.

The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company’s and its subsidiaries’ ability to, among other things, grant liens, make investments, incur indebtedness, merge or consolidate, dispose of assets, make acquisitions, pay dividends or make distributions, repurchase stock, enter into transactions with affiliates and enter into restrictive agreements, in each case subject to customary exceptions for a credit facility of this size and type. The Company is also required to maintain compliance with a consolidated fixed charge coverage ratio and a consolidated secured leverage ratio. The Company was in compliance with these covenants as of March 31, 2014.

The Credit Agreement includes customary events of default that include, among other things, non-payment defaults, covenant defaults, inaccuracy of representations and warranties, cross default to material indebtedness, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults and a change of control default. The occurrence of an event of default could result in the acceleration of the obligations under the Credit Agreement. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Credit Agreement at a per annum rate equal to 2.00% above the applicable interest rate for any overdue principal and 2.00% above the rate applicable for base rate loans for any other overdue amounts.

At March 31, 2014, the weighted average interest rate on the Term Loan was 1.97%, the accrued interest on the Term Loan was $0.2 million, and the current and noncurrent portion of the outstanding Term Loan was $6.3 million and $240.6 million, respectively.

The following table sets forth total interest expense recognized on the Term Loan (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Contractual interest expense

$

1,229

 

 

$

 

Amortization of debt issuance costs

 

134

 

 

 

 

 

$

1,363

 

 

$

 

 

Investments and Fair Value Measurements
Investments and Fair Value Measurements

11. INVESTMENTS AND FAIR VALUE MEASUREMENTS

The Company had cash and cash equivalents of $380.2 million and $392.6 million at March 31, 2014 and December 31, 2013, respectively. Cash and cash equivalents consist of cash in banks, as well as highly liquid investments in money market funds, time deposits, savings accounts, commercial paper, U.S. government and agency securities, municipal securities and corporate debt securities. At March 31, 2014, the Company’s long-term investments had contractual maturities of one to two years.

In addition, the Company has short-term and long-term investments in debt securities which are summarized as follows (in thousands):

 

 

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

Balances at March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

27,221

 

 

$

18

 

 

$

 

 

$

27,239

 

U.S. government agency securities

 

46,971

 

 

 

25

 

 

 

(3

)

 

 

46,993

 

Non-U.S. government securities

 

12,879

 

 

 

10

 

 

 

 

 

 

12,889

 

Corporate debt securities

 

62,744

 

 

 

30

 

 

 

(5

)

 

 

62,769

 

Total investments - short-term

$

149,815

 

 

$

83

 

 

$

(8

)

 

$

149,890

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,174

 

 

$

8

 

 

$

(4

)

 

$

19,178

 

U.S. government agency securities

 

26,539

 

 

 

9

 

 

 

(13

)

 

 

26,535

 

Corporate debt securities

 

20,131

 

 

 

7

 

 

 

(16

)

 

 

20,122

 

Total investments - long-term

$

65,844

 

 

$

24

 

 

$

(33

)

 

$

65,835

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,792

 

 

$

9

 

 

$

 

 

$

19,801

 

U.S. government agency securities

 

38,388

 

 

 

16

 

 

 

(3

)

 

 

38,401

 

Non-U.S. government securities

 

13,734

 

 

 

10

 

 

 

 

 

 

13,744

 

Corporate debt securities

 

62,720

 

 

 

22

 

 

 

(4

)

 

 

62,738

 

Total investments - short-term

$

134,634

 

 

$

57

 

 

$

(7

)

 

$

134,684

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

12,252

 

 

$

8

 

 

$

 

 

$

12,260

 

U.S. government agency securities

 

30,627

 

 

 

12

 

 

 

(3

)

 

 

30,636

 

Non-U.S. government securities

 

2,305

 

 

 

4

 

 

 

 

 

 

2,309

 

Corporate debt securities

 

11,152

 

 

 

15

 

 

 

 

 

 

11,167

 

Total investments - long-term

$

56,336

 

 

$

39

 

 

$

(3

)

 

$

56,372

 

 

As of March 31, 2014, the Company’s total cash and cash equivalents and investments held in the United States totaled $212.5 million with the remaining $383.4 million held by various foreign subsidiaries outside of the United States.

Unrealized Losses

The following table summarizes the fair value and gross unrealized losses of the Company’s investments, including those that are categorized as cash equivalents, with unrealized losses aggregated by type of investment instrument and length of time that individual securities have been in a continuous unrealized loss position as of March 31, 2014 and December 31, 2013 (in thousands):

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

9,067

 

 

$

(4

)

 

$

 

 

$

 

 

$

9,067

 

 

$

(4

)

U.S. government agency securities

 

20,114

 

 

 

(16

)

 

 

 

 

 

 

 

 

20,114

 

 

 

(16

)

Corporate debt securities

 

25,167

 

 

 

(21

)

 

 

 

 

 

 

 

 

25,167

 

 

 

(21

)

Total investments

$

54,348

 

 

$

(41

)

 

$

 

 

$

 

 

$

54,348

 

 

$

(41

)

December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

$

5,533

 

 

$

(6

)

 

$

 

 

$

 

 

$

5,533

 

 

$

(6

)

Corporate debt securities

 

9,837

 

 

 

(3

)

 

 

1,504

 

 

 

(1

)

 

 

11,341

 

 

 

(4

)

Total investments

$

15,370

 

 

$

(9

)

 

$

1,504

 

 

$

(1

)

 

$

16,874

 

 

$

(10

)

The Company reviews the individual securities in its portfolio to determine whether a decline in a security’s fair value below the amortized cost basis is other-than-temporary. If the decline in fair value is considered to be other-than-temporary, the cost basis of the individual security is written down to its fair value as a new cost basis and the amount of the write-down is accounted for as a realized loss and included in earnings. During the three months ended March 31, 2014 and 2013, the Company determined that there were no investments in its portfolio that were other-than temporarily impaired.

Private Company Investments

The Company has made various strategic investments in private companies. The private company investments are carried at cost and written down to their estimated net realizable value when indications exist that these investments have been impaired. The Company did not record such impairment charges during the three months ended March 31, 2014 and 2013. The cost of these investments at both March 31, 2014 and December 31, 2013 was $2.0 million, and has been recorded in “Other assets” in the Company’s condensed consolidated balance sheets.

Fair Value Measurements

Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As the basis for considering such assumptions, a three-tier value hierarchy prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company measures certain financial assets and liabilities at fair value, including its marketable securities and foreign currency contracts.

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using inputs such as quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. The types of instruments valued based on quoted market prices for identical assets in active markets include money market funds and are generally classified within Level 1 of the fair value hierarchy.

The types of instruments valued based on other observable inputs include U.S. Treasury securities and other government agencies, corporate bonds and commercial paper. Such instruments are generally classified within Level 2 of the fair value hierarchy. Level 2 instruments are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. There have been no transfers between Level 1 and Level 2 during the three months ended March 31, 2014 and 2013. The Company does not hold any investments classified as Level 3 as of March 31, 2014 and December 31, 2013.

As of March 31, 2014, the Company’s fixed income available-for-sale securities include U.S. Treasury obligations and other government agency instruments (52%), corporate bonds (24%), commercial paper (17%), non-U.S. Government securities (6%), and money market funds (1%). Included in available-for-sale securities is approximately $18.2 million of cash equivalents, which consist of investments with original maturities of three months or less and include money market funds.

The principal market where the Company executes its foreign currency contracts is the retail market in an over-the-counter environment with a relatively high level of price transparency. The market participants and the Company’s counterparties are large money center banks and regional banks. The Company’s foreign currency contracts valuation inputs are based on quoted prices and quoted pricing intervals from public data sources such as spot rates, interest rate differentials and credit default rates, which do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.

The Company’s Term Loan under its Credit Agreement is classified within Level 2 instruments as the borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to the Company for debt with similar terms and maturities. See Note 10. The Company has elected not to record its Term Loan at fair value, but has measured it at fair value for the disclosure purpose. At March 31, 2014, the carrying amount of the Term Loan approximated its estimated fair value based on observable market inputs.

The fair value of the Company’s marketable securities and foreign currency contracts was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements at

March 31, 2014 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

233,916

 

 

$

3,507

 

 

$

230,409

 

Foreign currency forward contracts (b)

 

$

5,448

 

 

$

 

 

$

5,448

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,172

 

 

$

 

 

$

6,172

 

 

 

 

 

 

 

 

Fair Value Measurements at

December 31, 2013 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

211,151

 

 

$

17,596

 

 

$

193,555

 

Foreign currency forward contracts (b)

 

$

6,748

 

 

$

 

 

$

6,748

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,780

 

 

$

 

 

$

6,780

 

________________

(a)

Included in cash and cash equivalents, and short and long-term investments on the Company’s condensed consolidated balance sheets.

(b)

Included in short-term derivative assets as prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets.

(c)

Included in short-term derivative liabilities as other accrued liabilities on the Company’s condensed consolidated balance sheets.

The Company’s current accounting policy and practice is not to offset derivative assets and liabilities in its condensed consolidated balance sheets. See Note 12.

Foreign Currency Derivatives
Foreign Currency Derivatives

12. FOREIGN CURRENCY DERIVATIVES

The Company maintains a foreign currency risk management program that is designed to reduce the volatility of the Company’s economic value from the effects of unanticipated currency fluctuations. International operations generate both revenues and costs denominated in foreign currencies. The Company’s policy is to hedge significant foreign currency revenues and costs to improve margin visibility and reduce earnings volatility associated with unexpected changes in currency.

Non-Designated Hedges

The Company hedges its net foreign currency monetary assets and liabilities primarily resulting from foreign currency denominated revenues and expenses with foreign exchange forward contracts to reduce the risk that the Company’s earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments are carried at fair value with changes in the fair value recorded as interest and other income (expense), net. These derivative instruments do not subject the Company to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset remeasurement gains and losses on the hedged assets and liabilities. The Company executes non-designated foreign exchange forward contracts primarily denominated in Euros, British Pounds, Israeli Shekels, Brazilian Reals, Chinese Yuan, Japanese Yen and Mexican Pesos.

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent, at March 31, 2014 of the outstanding non-designated hedges (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Brazilian Real

 

 

5,200

 

 

$

2,298

 

 

Buy

 

 

 

 

$

 

 

 

 

Brazilian Real

 

 

9,374

 

 

$

4,033

 

 

Sell

 

 

 

 

 

 

 

 

 

Chinese Yuan

 

 

46,376

 

 

$

7,581

 

 

Buy

 

 

 

 

$

 

 

 

 

Chinese Yuan

 

 

39,267

 

 

$

6,380

 

 

Sell

 

 

 

 

$

 

 

 

 

Euro

 

 

26,445

 

 

$

36,444

 

 

Buy

 

 

12,308

 

 

$

16,037

 

 

Buy

 

Euro

 

 

52,904

 

 

$

72,958

 

 

Sell

 

 

23,600

 

 

$

30,843

 

 

Sell

 

British Pound

 

 

13,459

 

 

$

22,484

 

 

Buy

 

 

8,366

 

 

$

12,693

 

 

Buy

 

British Pound

 

 

7,712

 

 

$

12,857

 

 

Sell

 

 

17,031

 

 

$

26,037

 

 

Sell

 

Israeli Shekel

 

 

22,544

 

 

$

6,463

 

 

Buy

 

 

43,549

 

 

$

11,752

 

 

Buy

 

Israeli Shekel

 

 

57,236

 

 

$

16,399

 

 

Sell

 

 

 

 

$

 

 

 

 

Japanese Yen

 

 

440,575

 

 

$

4,269

 

 

Buy

 

 

 

 

$

 

 

 

 

Japanese Yen

 

 

851,223

 

 

$

8,290

 

 

Sell

 

 

 

 

$

 

 

 

 

Mexican Peso

 

 

12,359

 

 

$

948

 

 

Buy

 

 

 

 

$

 

 

 

 

Mexican Peso

 

 

24,961

 

 

$

1,894

 

 

Sell

 

 

 

 

$

 

 

 

 

The following table shows the effect of the Company’s non-designated hedges in the condensed consolidated statements of operations (in thousands):

 

Derivatives Not Designated as

Hedging Instruments

 

Location of Gain or (Loss)

Recognized in Income on Derivative

 

Amount of Gain or (Loss)

Recognized in Income on Derivative

 

 

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

2014

 

 

March 31,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

334

 

 

$

2,333

 

Cash Flow Hedges

The Company’s foreign exchange risk management program objective is to reduce volatility in the Company’s economic value from unanticipated foreign currency fluctuations. The Company designates forward contracts as cash flow hedges of foreign currency revenues and expenses, primarily the Chinese Yuan, Euros, British Pounds and Israeli Shekels. All foreign exchange contracts are carried at fair value on the condensed consolidated balance sheets and the maximum duration of foreign exchange forward contracts does not exceed thirteen months. Speculation is prohibited by policy.

To receive hedge accounting treatment under ASC 815, Derivatives and Hedging, all cash flow hedging relationships are formally designated at hedge inception, and tested both prospectively and retrospectively to ensure the forward contracts are highly effective in offsetting changes to future cash flows on the hedged transactions. The Company records effective spot to spot changes in these cash flow hedges in cumulative other comprehensive income until they are reclassified to revenue, cost of revenue or operating expenses together with the hedged transaction. The time value on forward contracts is excluded from effectiveness testing and recorded to interest and other income (expense), net over the life of the contract together with any ineffective portion of the hedge.

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent, at March 31, 2014 of the outstanding cash flow hedges (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

 

Positions

 

Chinese Yuan

 

 

101,324

 

 

$

16,367

 

 

Buy

 

 

 

 

$

 

 

 

 

 

Euro

 

 

8,800

 

 

$

12,127

 

 

Buy

 

 

15,392

 

 

$

20,526

 

 

 

Buy

 

Euro

 

 

29,200

 

 

$

40,240

 

 

Sell

 

 

31,500

 

 

$

42,200

 

 

 

Sell

 

British Pound

 

 

9,500

 

 

$

15,792

 

 

Buy

 

 

12,634

 

 

$

19,868

 

 

 

Buy

 

British Pound

 

 

14,100

 

 

$

23,439

 

 

Sell

 

 

8,069

 

 

$

12,884

 

 

 

Sell

 

Israeli Shekel

 

 

19,100

 

 

$

5,468

 

 

Buy

 

 

56,951

 

 

$

15,878

 

 

 

Buy

 

The following tables show the effect of the Company’s derivative instruments designated as cash flow hedges in the condensed consolidated statements of operations for the three months ended March 31, 2014 and 2013 (in thousands):

 

Three Months Ended

March 31, 2014:

 

Gain

or (Loss)

Recognized in

OCI-Effective

Portion

 

 

Location of

Gain or (Loss)

Reclassified

from OCI into

Income-Effective

Portion

 

Gain or (Loss)

Reclassified

from OCI into

Income-Effective

Portion

 

 

Location of

Gain or (Loss)

Recognized-

Ineffective Portion

and Amount Excluded from

Effectiveness Testing

 

Gain or (Loss)

Recognized-

Ineffective Portion

and Amount

Excluded from

Effectiveness

Testing (a)

 

Foreign exchange contracts

 

$

(421

)

 

Product revenues

 

$

(2,865

)

 

Interest and other income (expense), net

 

$

75

 

 

 

 

 

 

 

Cost of revenues

 

 

532

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

1,080

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

415

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

172

 

 

 

 

 

 

 

Total

 

$

(421

)

 

 

 

$

(666

)

 

 

 

$

75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

March 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

2,957

 

 

Product revenues

 

$

627

 

 

Interest and other income (expense), net

 

$

 

 

 

 

 

 

 

Cost of revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

178

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

(103

)

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

12

 

 

 

 

 

 

 

Total

 

$

2,957

 

 

 

 

$

714

 

 

 

 

$

 

_______________________

(a)

For both the three months ended March 31, 2014 and 2013, there were no gains or losses recognized in income due to ineffectiveness.                                   

As of March 31, 2014, the Company estimated that all values reported in accumulated other comprehensive income (loss) will be reclassified to income within the next twelve months.

In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge would be immediately reclassified to interest and other income (expense), net on the consolidated statements of operations. For the three months ended March 31, 2014 and 2013, there were no such gains or losses.

The estimates of fair value are based on applicable and commonly quoted prices and prevailing financial market information as of March 31, 2014 and December 31, 2013. See Note 11 for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and derivative liabilities that are measured at fair value in the condensed consolidated financial statements on a recurring basis.

The following table shows the Company’s derivative instruments measured at gross fair value as reflected in the condensed consolidated balance sheets as of the periods presented (in thousands):

 

 

Fair Value of

Derivatives Designated

as Hedge Instruments

 

 

Fair Value of Derivatives

Not Designated as Hedge

Instruments

 

 

March 31,

2014

 

 

December 31,

2013

 

 

March 31,

2014

 

 

December 31,

2013

 

Derivative assets (a):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

2,303

 

 

$

4,457

 

 

$

3,145

 

 

$

2,291

 

Derivative liabilities (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

1,854

 

 

$

4,235

 

 

$

4,318

 

 

$

2,545

 

______________

(a)

All derivative assets are recorded as prepaid and other current assets in the condensed consolidated balance sheets.

(b)

All derivative liabilities are recorded as other accrued liabilities in the condensed consolidated balance sheets.

Offsetting Derivative Assets and Liabilities

The Company has entered into master netting arrangements with each of its derivative counterparties. These arrangements afford the right to net derivative assets against liabilities with the same counterparty. Under certain default provisions, the Company has the right to setoff any other amounts payable to the payee whether or not arising under this agreement. As a result of the netting provisions, the Company’s maximum amount of loss under derivative transactions due to credit risk is limited to the net amounts due from the counterparties under the derivative contracts. Although netting is permitted, it is currently the Company’s policy and practice to record all derivative assets and liabilities on a gross basis in the condensed consolidated balance sheets.

The following table sets forth the offsetting of derivative assets (in thousands):

 

 

 

Gross
Amounts of
Recognized
Assets

 

 

Gross Amounts

Offset in the
Condensed
Consolidated

Balance Sheets

 

 

Net Amounts Of
Assets Presented In
the Condensed
Consolidated
Balance Sheets

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

5,448

 

 

$

 

 

$

5,448

 

 

$

(4,493

)

 

$

 

 

$

955

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,748

 

 

$

 

 

$

6,748

 

 

$

(5,643

)

 

$

 

 

$

1,105

 

The following table sets forth the offsetting of derivative liabilities (in thousands):

 

 

 

Gross
Amounts of
Recognized
Liabilities

 

 

Gross Amounts

Offset in the
Condensed
Consolidated

Balance Sheets

 

 

Net Amounts Of
Liabilities
Presented In the
Condensed
Consolidated
Balance Sheets

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,172

 

 

$

 

 

$

6,172

 

 

$

(4,493

)

 

$

 

 

$

1,679

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,780

 

 

$

 

 

$

6,780

 

 

$

(5,643

)

 

$

 

 

$

1,137

 

 

Stockholders' Equity
Stockholders' Equity

13. STOCKHOLDERS’ EQUITY

Share Repurchase Program

From time to time, the Company’s Board of Directors has approved plans under which the Company may at its discretion purchase shares of its common stock in the open market or via privately negotiated transactions. During the three months ended March 31, 2013, the Company purchased approximately 3.4 million shares of common stock in the open market for $34.2 million. The Company did not purchase any shares of common stock in the open market during the three months ended March 31, 2014. The purchase price for the shares of the Company’s stock repurchased is recorded as a reduction to stockholders’ equity. The excess of the cost of treasury stock that is retired over the fair value based on the calculated average price in equity is recorded as a charge to retained earnings.

In September 2013, the Company announced that its Board of Directors had authorized the repurchase of $400.0 million, or approximately 20 percent, of the Company’s outstanding common stock (“Return of Capital Program”), through a $250.0 million modified “Dutch Auction” self-tender offer (the “Tender Offer”) and subsequent open market purchases or privately negotiated transactions. The Company funded the program with $150.0 million in cash and its $250.0 million Term Loan (see Note 10).

Modified “Dutch Auction” Self-Tender Offer

The Tender Offer expired on October 30, 2013. The Company accepted for payment an aggregate of 27.4 million shares of its common stock at a purchase price of $10.40 per share, for an aggregate cost of approximately $285.4 million, excluding fees and expenses relating to the Tender Offer. The excess of the purchase price over the fair value on the date the shares were tendered was not material and no charge was recorded in the Company’s consolidated statements of operations. The costs associated with the Tender Offer were accounted for as an adjustment to the stockholders’ equity.

Accelerated Share Repurchase Agreements

On December 4, 2013, the Company entered into separate accelerated share repurchase (“ASR”) agreements with two financial institutions to repurchase an aggregate of $114.6 million of common stock as part of the last phase of the Company’s $400.0 million Return of Capital Program. Under the terms of the ASR agreements, the Company paid an aggregate $114.6 million of cash and received an initial delivery of approximately 8.0 million shares on December 5, 2013 that were valued at approximately $86.7 million, based on the closing price of the Company’s stock on the date of delivery. Those initially repurchased shares were retired and accounted for as a reduction to stockholders’ equity. The final number of shares to be repurchased will be based on the Company’s volume-weighted average stock price (“VWAP”) less an agreed upon discount during the term of the transactions. The purchase price for the shares to be settled pursuant to the holdback provision of the ASR agreements was approximately $27.9 million, based on the closing price of the Company’s stock on December 5, 2013, and was accounted for as a forward contract indexed to the Company’s own common stock, which was classified as an equity instrument and was recorded as a decrease in additional paid-in capital. The costs associated with the ASR transactions were recorded as an adjustment to the stockholders’ equity. Additionally, the Company accounted for the ASR transactions as repurchases of common stock for the purpose of calculating its earnings per share. The transactions are expected to be completed by June 30, 2014 or earlier at the option of the counterparties, or later under certain circumstances. The terms of the ASR agreements are subject to changes if the Company were to enter into or announce certain types of transactions. If the Company is obligated to make an adjustment payment to the counterparties upon settlement, based on the VWAP, the Company may elect to satisfy such obligation in cash or in shares of Polycom’s common stock.

Accumulated Other Comprehensive Income

The following table summarizes the changes in accumulated other comprehensive income, net of tax, by component for the three months ended March 31, 2014 (in thousands). The tax effects were not shown separately, as the impacts were not material.

 

Three Months Ended March 31, 2014

 

Unrealized

Gains and

Losses on

Cash Flow

Hedges

 

 

Unrealized Gains

and Losses on

Available-for-

Sale Securities

 

 

Foreign Currency

Translation

 

 

Total

 

Balance as of December 31, 2013

 

$

80

 

 

$

73

 

 

$

4,219

 

 

$

4,372

 

Other comprehensive income (loss) before reclassifications

 

 

(421

)

 

 

(7

)

 

 

(1,203

)

 

 

(1,631

)

Amounts reclassified from accumulated

     other comprehensive income (a)

 

 

666

 

 

 

(1

)

 

 

 

 

 

665

 

Net current-period other comprehensive income (loss)

 

 

245

 

 

 

(8

)

 

 

(1,203

)

 

 

(966

)

Balance as of March 31, 2014

 

$

325

 

 

$

65

 

 

$

3,016

 

 

$

3,406

 

_____________

 

(a)

See Note 12 of Notes to Condensed Consolidated Financial Statements for details of gains and losses, net of taxes, reclassified out of accumulated other comprehensive income into net income related to cash flow hedges and each line item of net income affected by the reclassification. Gains and losses related to available-for-sale securities were reclassified into “Other income (expense)” in the condensed consolidated statement of operations for the three months ended March 31, 2014, net of taxes.

 

Stock-Based Compensation
Stock-Based Compensation

14. STOCK-BASED COMPENSATION

The following table summarizes stock-based compensation expense recorded for the three months ended March 31, 2014 and 2013 and its allocation within the condensed consolidated statements of operations (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Cost of sales - product

$

640

 

 

$

861

 

Cost of sales - service

 

961

 

 

 

1,476

 

Stock-based compensation expense included in cost of sales

 

1,601

 

 

 

2,337

 

 

 

 

 

 

 

 

 

Sales and marketing

 

391

 

 

 

6,636

 

Research and development

 

1,042

 

 

 

4,721

 

General and administrative

 

2,613

 

 

 

4,077

 

Stock-based compensation expense included in operating

     expenses

 

4,046

 

 

 

15,434

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases

 

5,647

 

 

 

17,771

 

Tax benefit

 

985

 

 

 

3,895

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases, net of tax

$

4,662

 

 

$

13,876

 

 

Stock-based compensation expense is not allocated to segments because it is centrally managed at the corporate level.

Stock Options

There were no stock options granted in the three months ended March 31, 2014 and 2013.

Performance Shares and Restricted Stock Units

During the three months ended March 31, 2014 and 2013, the Company granted 450,580 and 1,217,185, respectively, of performance shares to certain employees and executives, at a weighted average fair value of $13.87 and $8.76 per share, respectively. The 2014 and 2013 grants are generally divided evenly over three annual performance periods commencing with calendar year 2014 and 2013, respectively.

During the three months ended March 31, 2014 and 2013, the Company granted 2,582,618 and 2,299,772, respectively, of restricted stock units at a weighted average fair value of $12.97 and $9.38 per share, respectively.

 

During the three months ended March 31, 2014 and 2013, there were no restricted stock units granted to non-employee directors.

Employee Stock Purchase Plan

During the three months ended March 31, 2014 and 2013, 1,696,177 and 1,634,299 shares were purchased under ESPP, respectively. As of March 31, 2014, there were 3,562,959 shares available to be issued under the Company’s employee stock purchase plan (“ESPP”).

Valuation Assumptions

For purchase rights granted pursuant to the ESPP, the estimated fair value per share of employee stock purchase rights for the two-year offering period commencing on February 3, 2014 ranged from $2.82 to $4.48, compared to the estimated fair value per share from $2.93 to $4.57 for the two-year offering period commencing on February 1, 2013.

The fair value of each employee stock purchase right grant is estimated on the date of grant using the Black-Scholes option valuation model and is recognized as expense using the graded vesting method using the following assumptions:

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Expected volatility

32.30-42.11%

 

 

44.76-50.55%

 

Risk-free interest rate

0.07-0.30%

 

 

0.11-0.27%

 

Expected dividends

 

0.0%

 

 

 

0.0%

 

Expected life (yrs)

0.5-2.0

 

 

0.5-2.0

 

The Company computed its expected volatility assumption based on blended volatility (50% historical volatility and 50% implied volatility). The selection of the blended volatility assumption was based upon the Company’s assessment that blended volatility is more representative of the Company’s future stock price trends as it weighs in the longer term historical volatility with the near term future implied volatility.

The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected life of the Company’s employee stock purchases.

The dividend yield assumption is based on the Company’s history of not paying dividends and future expectation of dividend payouts.

The expected life of employee stock purchase rights represents the contractual terms of the underlying program.

During the three months ended March 31, 2014, the Company performed its annual review of assumptions which resulted in an increase in the forfeiture rate. The effect of the change in the forfeiture rate decreased stock-based compensation expense by approximately $1.8 million which decreased net loss by approximately $1.4 million or $0.01 per share in the three months ended March 31, 2014. The Company does not expect a material impact from the change in the forfeiture rate during the remainder of 2014. Additionally, during the three months ended March 31, 2014, the Company recorded a benefit of $2.1 million related to actual forfeitures of awards granted to former officers.

Net Income (Loss) Per Share
Net Income (Loss) Per Share

15. NET INCOME (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted net income (loss) per share for the periods presented (in thousands, except for per-share amounts):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

Net income (loss) from continuing operations

$

(3,991

)

 

$

2,117

 

Gain from sale of discontinued operations, net of taxes

 

 

 

 

459

 

Net income (loss)

$

(3,991

)

 

$

2,576

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

136,795

 

 

 

176,079

 

Effect of dilutive potential common shares

 

 

 

 

3,061

 

Weighted average shares outstanding, diluted

 

136,795

 

 

 

179,140

 

 

 

 

 

 

 

 

 

Basic net income (loss) per share

 

 

 

 

 

 

 

Net income (loss) per share from continuing operations

$

(0.03

)

 

$

0.01

 

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

$

(0.03

)

 

$

0.01

 

 

 

 

 

 

 

 

 

Diluted net income (loss) per share

 

 

 

 

 

 

 

Net income (loss) per share from continuing operations

$

(0.03

)

 

$

0.01

 

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

$

(0.03

)

 

$

0.01

 

 

 

 

 

 

 

 

 

Antidilutive employee stock-based awards, excluded

 

5,855

 

 

 

1,717

 

Diluted shares outstanding include the dilutive effect of in-the-money employee equity share options, unvested performance shares, restricted stock units, and stock purchase rights under ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net income (loss) per share when their effect is antidilutive.

Business Segment Information
Business Segment Information

16. BUSINESS SEGMENT INFORMATION

The Company conducts its business globally and is managed geographically in three segments: (1) Americas, which consist of North America and Caribbean and Latin America (“CALA”) reporting units, (2) Europe, Middle East and Africa (“EMEA”) and (3) Asia Pacific (“APAC”). The segments are determined in accordance with how management views and evaluates the Company’s business and allocates its resources, and based on the criteria as outlined in the authoritative guidance.

Segment Revenue and Profit

Segment revenues are attributed to a theater based on the ordering location of the customer. A significant portion of each segment’s expenses arise from shared services and infrastructure that Polycom has historically allocated to the segments in order to realize economies of scale and to use resources efficiently.

Segment contribution margin includes all geographic segment revenues less the related cost of sales and direct sales and marketing expenses. Management allocates some infrastructure costs, such as facilities and IT costs, in determining segment contribution margins. Contribution margin is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. Certain operating expenses are not allocated to segments because they are separately managed at the corporate level. These unallocated costs include corporate manufacturing costs, sales and marketing costs other than direct sales and marketing expenses, research and development expenses, general and administrative costs, such as legal and accounting, stock-based compensation costs, transaction-related costs, amortization of purchased intangibles, restructuring costs and interest and other income (expense), net.

Segment Data

The results of the reportable segments are derived directly from Polycom’s management reporting system. The results are based on Polycom’s method of internal reporting and are not reported in conformity with accounting principles generally accepted in the United States. Management measures the performance of each segment based on several metrics, including contribution margin as defined above. For internal reporting purposes and determination of segment contribution margins, geographic segment revenues may differ slightly from actual geographic revenues due to internal revenue allocations between the Company’s segments. Asset data, with the exception of gross accounts receivable, is not reviewed by management at the segment level.

Financial information for each reportable geographical segment as of March 31, 2014 and December 31, 2013 and for the three months ended March 31, 2014 and 2013, based on the Company’s internal management reporting system and as utilized by the Company’s Chief Executive Officer who is its Chief Operating Decision Maker (“CODM”), is as follows (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

For the three months ended March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

163,070

 

 

$

89,036

 

 

$

76,418

 

 

$

328,524

 

% of total revenue

 

50

%

 

 

27

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,973

 

 

 

37,666

 

 

 

31,655

 

 

 

139,294

 

% of segment revenue

 

43

%

 

 

42

%

 

 

41

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended March 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

170,981

 

 

$

89,092

 

 

$

78,679

 

 

$

338,752

 

% of total revenue

 

51

%

 

 

26

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,229

 

 

 

37,560

 

 

 

30,845

 

 

 

137,634

 

% of segment revenue

 

40

%

 

 

42

%

 

 

39

%

 

 

41

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of March 31, 2014: Gross accounts receivable

$

91,399

 

 

$

71,734

 

 

$

60,917

 

 

$

224,050

 

% of total gross accounts receivable

 

41

%

 

 

32

%

 

 

27

%

 

 

100

%

As of December 31, 2013: Gross accounts receivable

 

86,243

 

 

 

71,970

 

 

 

66,921

 

 

 

225,134

 

% of total gross accounts receivable

 

38

%

 

 

32

%

 

 

30

%

 

 

100

%

During the three months ended March 31, 2014 and 2013, one customer from the Americas segment, ScanSource Communications (“ScanSource”), accounted for 18% and 17%, respectively, of the Company’s revenues. At March 31, 2014 and December 31, 2013, ScanSource accounted for 15% and 11%, respectively, of total gross accounts receivable.

 

The reconciliation of segment information to Polycom consolidated totals is as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Segment contribution margin

$

139,294

 

 

$

137,634

 

Corporate and unallocated costs

 

(106,600

)

 

 

(107,705

)

Stock-based compensation

 

(5,647

)

 

 

(17,771

)

Effect of stock-based compensation cost on warranty expense

 

(129

)

 

 

(157

)

Transaction-related costs

 

(156

)

 

 

(3,323

)

Amortization of purchased intangibles

 

(3,333

)

 

 

(3,750

)

Restructuring costs

 

(30,343

)

 

 

(5,423

)

Interest and other income (expense), net

 

(695

)

 

 

(759

)

Loss from continuing operations before benefit from income taxes

$

(7,609

)

 

$

(1,254

)

 

 

March 31,

2014

 

 

December 31,

2013

 

Gross accounts receivables

$

224,050

 

 

$

225,134

 

Returns and related reserves

 

(37,006

)

 

 

(38,938

)

Allowance for doubtful accounts

 

(2,805

)

 

 

(2,827

)

Total trade receivables, net

$

184,239

 

 

$

183,369

 

The following table summarizes the Company’s revenues by groups of similar products and services as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Revenues:

 

 

 

 

 

 

 

UC group systems

$

213,372

 

 

$

232,426

 

UC personal devices

 

56,474

 

 

 

49,246

 

UC platform

 

58,678

 

 

 

57,080

 

Total

$

328,524

 

 

$

338,752

 

 

Income Taxes
Income Taxes

17. INCOME TAXES

The following table presents the income tax benefit from continuing operations and the effective tax rates (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Income tax benefit from continuing operations

$

(3,618

)

 

$

(3,371

)

Effective tax rate

 

47.5

%

 

 

268.8

%

For the three months ended March 31, 2014 and 2013, the Company recorded income tax benefits of $3.6 million and $3.4 million, respectively. The effective tax rates for the three months ended March 31, 2014 and 2013 were 47.5% and 268.8%, respectively, and differ from the U.S. federal statutory rate of 35% primarily due to impacts associated with proportional earnings from the Company’s operations in lower tax jurisdictions, recurring permanent adjustments, and discrete benefits recorded during the quarters. For the three months ended March 31, 2014, a discrete benefit of $1.3 million was recorded for tax benefits realized on disqualifying dispositions of stock from the Company’s employee stock purchase plan, and a discrete tax benefit of $0.9 million was recorded as a result of stock-based compensation expense adjustments related to certain terminated employees. For the three months ended March 31, 2013, a discrete benefit of $2.2 million was recorded related to the reinstatement of the federal research and development tax credit signed into law on January 2, 2013, but retroactive to 2012, and a discrete benefit of $0.8 million was recorded for tax benefits realized on disqualifying dispositions of stock from the Company’s employee stock purchase plan.

As of March 31, 2014, the amount of gross unrecognized tax benefits was $22.1 million, all of which would affect the Company’s effective tax rate if realized. The Company recognizes interest income and interest expense and penalties on tax overpayments and underpayments within income tax expense. As of March 31, 2014 and December 31, 2013, the Company had approximately $1.5 million of accrued interest and penalties related to uncertain tax positions. The Company anticipates that, except for $0.9 million in uncertain tax positions that may be reduced related to the lapse of various statutes of limitation, there will be no material changes in uncertain tax positions in the next 12 months.

Contingencies
Contingencies

18. CONTINGENCIES

From time to time, the Company is involved in claims and legal proceedings that arise in the ordinary course of business. The Company expects that the number and significance of these matters will increase as business expands. In particular, the Company expects to face an increasing number of patent and other intellectual property claims as the number of products and competitors in Polycom’s industry grows and the functionality of video, voice, data and web conferencing products overlap. Any claims or proceedings against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require the Company to enter into royalty or licensing agreements which, if required, may not be available on terms favorable to the Company or at all. If management believes that a loss arising from these matters is probable and can be reasonably estimated, the Company will record a reserve for the loss. As additional information becomes available, any potential liability related to these matters is assessed and the estimates revised. Based on currently available information, management does not believe that the ultimate outcomes of these unresolved matters, individually and in the aggregate, are likely to have a material adverse effect on the Company’s financial position, liquidity or results of operations. However, litigation is subject to inherent uncertainties, and the Company’s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position and results of operations or liquidity for the period in which the unfavorable outcome occurs or becomes probable, and potentially in future periods.

Litigation and SEC Investigation

Following the July 23, 2013 announcement regarding the departure of the Company’s former CEO, the SEC initiated an investigation, a class action lawsuit was filed, and derivative lawsuits were filed, all as described below.

SEC Investigation. In July 2013, the Company was informed that the SEC was investigating the Audit Committee’s review of Mr. Miller’s expenses and his resignation. The investigation is ongoing, and the SEC has requested information from the Company. The Company is cooperating with the investigation.

Class Action Lawsuit. On July 26, 2013, a purported shareholder class action, captioned Neal v. Polycom Inc., et al., Case No.3:13-cv-03476-SC, was filed in the United States District Court for the Northern District of California against the Company and certain of its current and former officers and directors. On December 13, 2013, the Court appointed a lead plaintiff and approved lead and liaison counsel. On February 24, 2014,the lead plaintiff filed a first amended complaint. The amended complaint alleges that, between January 20, 2011 and July 23, 2013, the Company issued materially false and misleading statements or failed to disclose information regarding the Company’s business, operational and compliance policies, including with respect to its former Chief Executive Officer’s expense submissions and the Company’s internal controls. The lawsuit further alleges that the Company’s financial statements were materially false and misleading. The amended complaint alleges violations of the federal securities laws and seeks unspecified compensatory damages and other relief. The defendants filed motions to dismiss the amended complaint.  At this time we are unable to estimate any range of reasonably possible loss relating to the securities class action.

Derivative Lawsuits. On August 21, 2013 and October 16, 2013, two purported shareholder derivative suits, captioned Saraceni v. Miller, et al., Case No. 5:13-cv-03880, and Donnelly v. Miller, et al., Case No. 5:13-cv-04810, respectively, were filed in the United States District Court for the Northern District of California against certain of the Company’s current and former officers and directors. On October 31, 2013, these two federal derivative actions were consolidated into In re Polycom, Inc. Derivative Litigation, Lead Case No. 3:13-cv-03880. Plaintiffs filed an amended complaint on April 4, 2014.

On November 22, 2013 and December 13, 2013, two purported shareholder derivative suits, captioned Ware v. Miller, et al., Case No. 1-13-cv-256608, and Clem v. Miller, et al., Case No. 1-13-cv-257664, respectively, were filed in the Superior Court of California, County of Santa Clara, against certain of the Company’s current and former officers and directors. On January 31, 2014, these two California state derivative actions were consolidated into In re Polycom, Inc. Derivative Shareholder Litigation, Lead Case No. 1-13-cv-256608. The Company has filed a motion to stay the California state derivative litigation pending resolution of both the federal derivative lawsuit and the federal securities class action.

The Federal and California state consolidated derivative lawsuits purport to assert claims on behalf of the Company, which is named as a nominal defendant in the actions. The complaints allege claims for breach of fiduciary duty, unjust enrichment, and corporate waste, and allege certain defendants failed to maintain adequate internal controls and issued, or authorized the issuance of, materially false and misleading statements, including with respect to the Company’s former Chief Executive Officer’s expense submissions and the Company’s internal controls. The complaints further allege that certain defendants approved an unjustified separation agreement and caused the Company to repurchase its own stock at artificially inflated prices. The complaints seek unspecified compensatory damages, corporate governance reforms, and other relief. At this time we are unable to estimate any range of reasonably possible loss relating to the derivative actions.

Recent Accounting Pronouncements (Policies)
Recent Accounting Pronouncements

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update which clarifies that an unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations where a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The guidance is effective prospectively for reporting periods beginning after December 15, 2013. The Company adopted the guidance in the three months ended March 31, 2014, and such adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Basis of Presentation (Tables)
Revision to the Condensed Consolidated Statement of Cash Flows

The following table sets forth a summary of the revision to the condensed consolidated statement of cash flows for the following period (in thousands):

 

 

Three Months Ended March 31, 2013

 

 

As Previously

Reported

 

 

Adjustment

 

 

As Revised

 

Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

 

Amortization of discounts and premiums on investments, net

$

 

 

$

386

 

 

$

386

 

Net cash provided by operating activities

$

49,014

 

 

$

386

 

 

$

49,400

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

$

(55,368

)

 

$

(386

)

 

$

(55,754

)

Net cash provided by investing activities

$

1,444

 

 

$

(386

)

 

$

1,058

 

 

Goodwill, Purchased Intangibles, and Software Development Costs (Tables)

The following table presents the changes to the Company’s goodwill by segment during the three months ended March 31, 2014 (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

Balance at December 31, 2013

$

308,159

 

 

$

101,882

 

 

$

149,419

 

 

$

559,460

 

Foreign currency translation

 

 

 

 

 

 

 

(226

)

 

 

(226

)

Balance at March 31, 2014

$

308,159

 

 

$

101,882

 

 

$

149,193

 

 

$

559,234

 

 

The following table presents details of the Company’s total purchased intangible assets and capitalized software development costs as of the following periods (in thousands):

 

 

March 31, 2014

 

 

December 31, 2013

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

Core and developed technology

$

81,178

 

 

$

(77,793

)

 

$

3,385

 

 

$

81,178

 

 

$

(76,952

)

 

$

4,226

 

Customer and partner relationships

 

79,525

 

 

 

(51,248

)

 

 

28,277

 

 

 

79,525

 

 

 

(48,941

)

 

 

30,584

 

Non-compete agreements

 

1,800

 

 

 

(650

)

 

 

1,150

 

 

 

1,800

 

 

 

(500

)

 

 

1,300

 

Trade name

 

3,400

 

 

 

(3,124

)

 

 

276

 

 

 

3,400

 

 

 

(3,089

)

 

 

311

 

Other

 

4,462

 

 

 

(4,362

)

 

 

100

 

 

 

4,462

 

 

 

(4,343

)

 

 

119

 

Finite-lived intangible assets

 

170,365

 

 

 

(137,177

)

 

 

33,188

 

 

 

170,365

 

 

 

(133,825

)

 

 

36,540

 

Indefinite-lived trade name

 

918

 

 

 

 

 

 

918

 

 

 

918

 

 

 

 

 

 

918

 

Total acquired intangible assets

$

171,283

 

 

$

(137,177

)

 

$

34,106

 

 

$

171,283

 

 

$

(133,825

)

 

$

37,458

 

Software development costs for products to be sold

$

3,474

 

 

$

(484

)

 

$

2,990

 

 

$

2,365

 

 

$

(196

)

 

$

2,169

 

 

The following table summarizes the amortization expenses recorded in the following periods (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Amortization of purchased intangibles in revenues

$

19

 

 

$

18

 

Amortization of purchased intangibles in cost of product revenues

 

841

 

 

 

1,248

 

Amortization of purchased intangibles in operating expenses

 

2,492

 

 

 

2,502

 

Total amortization expenses of purchased intangibles

$

3,352

 

 

$

3,768

 

 

The estimated future amortization expense as of March 31, 2014 is as follows (in thousands):

 

Year ending December 31,

 

Amount

 

Remainder of 2014

 

$

9,539

 

2015

 

 

10,495

 

2016

 

 

8,484

 

2017

 

 

4,670

 

2018

 

 

 

Total

 

$

33,188

 

 

Restructuring Costs (Tables)
Summary of Activity of Restructuring Reserves

The following table summarizes the changes in the Company’s restructuring reserves during the three months ended March 31, 2014 (in thousands):

 

 

Severance/Other

 

 

Facilities

 

 

Total

 

Balance at December 31, 2013

$

1,143

 

 

$

33,786

 

 

$

34,929

 

Additions to the reserve

 

10,557

 

 

 

19,786

 

 

 

30,343

 

Non-cash write-offs

 

 

 

 

(3,359

)

 

 

(3,359

)

Cash payments and other usage

 

(8,264

)

 

 

(3,468

)

 

 

(11,732

)

Balance at March 31, 2014

$

3,436

 

 

$

46,745

 

 

$

50,181

 

 

Balance Sheet Details (Tables)

Inventories consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Raw materials

$

3,210

 

 

$

2,740

 

Work in process

 

1,002

 

 

 

840

 

Finished goods

 

99,068

 

 

 

99,729

 

 

$

103,280

 

 

$

103,309

 

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Non-trade receivables

$

9,245

 

 

$

9,251

 

Prepaid expenses

 

40,422

 

 

 

31,164

 

Derivative assets

 

5,448

 

 

 

6,748

 

Other current assets

 

3,867

 

 

 

3,189

 

 

$

58,982

 

 

$

50,352

 

 

Deferred revenues consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Short-term:

 

 

 

 

 

 

 

Service

$

171,041

 

 

$

170,701

 

Product

 

112

 

 

 

307

 

License

 

1,550

 

 

 

1,400

 

 

$

172,703

 

 

$

172,408

 

Long-term:

 

 

 

 

 

 

 

Service

$

82,003

 

 

$

83,092

 

Product

 

18

 

 

 

 

License

 

4,057

 

 

 

4,375

 

 

$

86,078

 

 

$

87,467

 

 

Other accrued liabilities consist of the following (in thousands):

 

 

March 31,

2014

 

 

December 31,

2013

 

Accrued expenses

$

20,658

 

 

$

22,515

 

Accrued co-op expenses

 

4,159

 

 

 

4,629

 

Restructuring reserves

 

20,060

 

 

 

11,238

 

Warranty obligations

 

10,006

 

 

 

9,475

 

Derivative liabilities

 

6,172

 

 

 

6,780

 

Employee stock purchase plan withholdings

 

4,132

 

 

 

10,883

 

Other accrued liabilities

 

11,654

 

 

 

12,224

 

 

$

76,841

 

 

$

77,744

 

 

Guarantees (Tables)

Changes in the warranty obligation which is included as a component of “Other accrued liabilities” on the condensed consolidated balance sheets are as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Balance at beginning of period

$

9,475

 

 

$

10,475

 

Accruals for warranties issued during the period

 

4,165

 

 

 

3,619

 

Actual charges against warranty reserve during the period

 

(3,634

)

 

 

(4,379

)

Balance at end of period

$

10,006

 

 

$

9,715

 

 

Changes in the deferred services revenue are as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Balance at beginning of period

$

253,793

 

 

$

241,773

 

Additions to deferred services revenue

 

85,894

 

 

 

87,752

 

Amortization of deferred services revenue

 

(86,643

)

 

 

(83,506

)

Balance at end of period

$

253,044

 

 

$

246,019

 

 

Debt (Tables)
Interest Expense Recognized Related to Term Loan

The following table sets forth total interest expense recognized on the Term Loan (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Contractual interest expense

$

1,229

 

 

$

 

Amortization of debt issuance costs

 

134

 

 

 

 

 

$

1,363

 

 

$

 

 

Investments and Fair Value Measurements (Tables)

In addition, the Company has short-term and long-term investments in debt securities which are summarized as follows (in thousands):

 

 

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

Balances at March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

27,221

 

 

$

18

 

 

$

 

 

$

27,239

 

U.S. government agency securities

 

46,971

 

 

 

25

 

 

 

(3

)

 

 

46,993

 

Non-U.S. government securities

 

12,879

 

 

 

10

 

 

 

 

 

 

12,889

 

Corporate debt securities

 

62,744

 

 

 

30

 

 

 

(5

)

 

 

62,769

 

Total investments - short-term

$

149,815

 

 

$

83

 

 

$

(8

)

 

$

149,890

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,174

 

 

$

8

 

 

$

(4

)

 

$

19,178

 

U.S. government agency securities

 

26,539

 

 

 

9

 

 

 

(13

)

 

 

26,535

 

Corporate debt securities

 

20,131

 

 

 

7

 

 

 

(16

)

 

 

20,122

 

Total investments - long-term

$

65,844

 

 

$

24

 

 

$

(33

)

 

$

65,835

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,792

 

 

$

9

 

 

$

 

 

$

19,801

 

U.S. government agency securities

 

38,388

 

 

 

16

 

 

 

(3

)

 

 

38,401

 

Non-U.S. government securities

 

13,734

 

 

 

10

 

 

 

 

 

 

13,744

 

Corporate debt securities

 

62,720

 

 

 

22

 

 

 

(4

)

 

 

62,738

 

Total investments - short-term

$

134,634

 

 

$

57

 

 

$

(7

)

 

$

134,684

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

12,252

 

 

$

8

 

 

$

 

 

$

12,260

 

U.S. government agency securities

 

30,627

 

 

 

12

 

 

 

(3

)

 

 

30,636

 

Non-U.S. government securities

 

2,305

 

 

 

4

 

 

 

 

 

 

2,309

 

Corporate debt securities

 

11,152

 

 

 

15

 

 

 

 

 

 

11,167

 

Total investments - long-term

$

56,336

 

 

$

39

 

 

$

(3

)

 

$

56,372

 

 

The following table summarizes the fair value and gross unrealized losses of the Company’s investments, including those that are categorized as cash equivalents, with unrealized losses aggregated by type of investment instrument and length of time that individual securities have been in a continuous unrealized loss position as of March 31, 2014 and December 31, 2013 (in thousands):

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

9,067

 

 

$

(4

)

 

$

 

 

$

 

 

$

9,067

 

 

$

(4

)

U.S. government agency securities

 

20,114

 

 

 

(16

)

 

 

 

 

 

 

 

 

20,114

 

 

 

(16

)

Corporate debt securities

 

25,167

 

 

 

(21

)

 

 

 

 

 

 

 

 

25,167

 

 

 

(21

)

Total investments

$

54,348

 

 

$

(41

)

 

$

 

 

$

 

 

$

54,348

 

 

$

(41

)

December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

$

5,533

 

 

$

(6

)

 

$

 

 

$

 

 

$

5,533

 

 

$

(6

)

Corporate debt securities

 

9,837

 

 

 

(3

)

 

 

1,504

 

 

 

(1

)

 

 

11,341

 

 

 

(4

)

Total investments

$

15,370

 

 

$

(9

)

 

$

1,504

 

 

$

(1

)

 

$

16,874

 

 

$

(10

)

 

The fair value of the Company’s marketable securities and foreign currency contracts was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements at

March 31, 2014 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

233,916

 

 

$

3,507

 

 

$

230,409

 

Foreign currency forward contracts (b)

 

$

5,448

 

 

$

 

 

$

5,448

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,172

 

 

$

 

 

$

6,172

 

 

 

 

 

 

 

 

Fair Value Measurements at

December 31, 2013 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

211,151

 

 

$

17,596

 

 

$

193,555

 

Foreign currency forward contracts (b)

 

$

6,748

 

 

$

 

 

$

6,748

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,780

 

 

$

 

 

$

6,780

 

________________

(a)

Included in cash and cash equivalents, and short and long-term investments on the Company’s condensed consolidated balance sheets.

(b)

Included in short-term derivative assets as prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets.

(c)

Included in short-term derivative liabilities as other accrued liabilities on the Company’s condensed consolidated balance sheets.

Foreign Currency Derivatives (Tables)

The following table shows the Company’s derivative instruments measured at gross fair value as reflected in the condensed consolidated balance sheets as of the periods presented (in thousands):

 

 

Fair Value of

Derivatives Designated

as Hedge Instruments

 

 

Fair Value of Derivatives

Not Designated as Hedge

Instruments

 

 

March 31,

2014

 

 

December 31,

2013

 

 

March 31,

2014

 

 

December 31,

2013

 

Derivative assets (a):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

2,303

 

 

$

4,457

 

 

$

3,145

 

 

$

2,291

 

Derivative liabilities (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

1,854

 

 

$

4,235

 

 

$

4,318

 

 

$

2,545

 

______________

(a)

All derivative assets are recorded as prepaid and other current assets in the condensed consolidated balance sheets.

(b)

All derivative liabilities are recorded as other accrued liabilities in the condensed consolidated balance sheets.

The following table sets forth the offsetting of derivative assets (in thousands):

 

 

 

Gross
Amounts of
Recognized
Assets

 

 

Gross Amounts

Offset in the
Condensed
Consolidated

Balance Sheets

 

 

Net Amounts Of
Assets Presented In
the Condensed
Consolidated
Balance Sheets

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

5,448

 

 

$

 

 

$

5,448

 

 

$

(4,493

)

 

$

 

 

$

955

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,748

 

 

$

 

 

$

6,748

 

 

$

(5,643

)

 

$

 

 

$

1,105

 

 

The following table sets forth the offsetting of derivative liabilities (in thousands):

 

 

 

Gross
Amounts of
Recognized
Liabilities

 

 

Gross Amounts

Offset in the
Condensed
Consolidated

Balance Sheets

 

 

Net Amounts Of
Liabilities
Presented In the
Condensed
Consolidated
Balance Sheets

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,172

 

 

$

 

 

$

6,172

 

 

$

(4,493

)

 

$

 

 

$

1,679

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,780

 

 

$

 

 

$

6,780

 

 

$

(5,643

)

 

$

 

 

$

1,137

 

 

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent, at March 31, 2014 of the outstanding non-designated hedges (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Brazilian Real

 

 

5,200

 

 

$

2,298

 

 

Buy

 

 

 

 

$

 

 

 

 

Brazilian Real

 

 

9,374

 

 

$

4,033

 

 

Sell

 

 

 

 

 

 

 

 

 

Chinese Yuan

 

 

46,376

 

 

$

7,581

 

 

Buy

 

 

 

 

$

 

 

 

 

Chinese Yuan

 

 

39,267

 

 

$

6,380

 

 

Sell

 

 

 

 

$

 

 

 

 

Euro

 

 

26,445

 

 

$

36,444

 

 

Buy

 

 

12,308

 

 

$

16,037

 

 

Buy

 

Euro

 

 

52,904

 

 

$

72,958

 

 

Sell

 

 

23,600

 

 

$

30,843

 

 

Sell

 

British Pound

 

 

13,459

 

 

$

22,484

 

 

Buy

 

 

8,366

 

 

$

12,693

 

 

Buy

 

British Pound

 

 

7,712

 

 

$

12,857

 

 

Sell

 

 

17,031

 

 

$

26,037

 

 

Sell

 

Israeli Shekel

 

 

22,544

 

 

$

6,463

 

 

Buy

 

 

43,549

 

 

$

11,752

 

 

Buy

 

Israeli Shekel

 

 

57,236

 

 

$

16,399

 

 

Sell

 

 

 

 

$

 

 

 

 

Japanese Yen

 

 

440,575

 

 

$

4,269

 

 

Buy

 

 

 

 

$

 

 

 

 

Japanese Yen

 

 

851,223

 

 

$

8,290

 

 

Sell

 

 

 

 

$

 

 

 

 

Mexican Peso

 

 

12,359

 

 

$

948

 

 

Buy

 

 

 

 

$

 

 

 

 

Mexican Peso

 

 

24,961

 

 

$

1,894

 

 

Sell

 

 

 

 

$

 

 

 

 

 

The following table shows the effect of the Company’s non-designated hedges in the condensed consolidated statements of operations (in thousands):

 

Derivatives Not Designated as

Hedging Instruments

 

Location of Gain or (Loss)

Recognized in Income on Derivative

 

Amount of Gain or (Loss)

Recognized in Income on Derivative

 

 

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

2014

 

 

March 31,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

334

 

 

$

2,333

 

 

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent, at March 31, 2014 of the outstanding cash flow hedges (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

 

Positions

 

Chinese Yuan

 

 

101,324

 

 

$

16,367

 

 

Buy

 

 

 

 

$

 

 

 

 

 

Euro

 

 

8,800

 

 

$

12,127

 

 

Buy

 

 

15,392

 

 

$

20,526

 

 

 

Buy

 

Euro

 

 

29,200

 

 

$

40,240

 

 

Sell

 

 

31,500

 

 

$

42,200

 

 

 

Sell

 

British Pound

 

 

9,500

 

 

$

15,792

 

 

Buy

 

 

12,634

 

 

$

19,868

 

 

 

Buy

 

British Pound

 

 

14,100

 

 

$

23,439

 

 

Sell

 

 

8,069

 

 

$

12,884

 

 

 

Sell

 

Israeli Shekel

 

 

19,100

 

 

$

5,468

 

 

Buy

 

 

56,951

 

 

$

15,878

 

 

 

Buy

 

 

The following tables show the effect of the Company’s derivative instruments designated as cash flow hedges in the condensed consolidated statements of operations for the three months ended March 31, 2014 and 2013 (in thousands):

 

Three Months Ended

March 31, 2014:

 

Gain

or (Loss)

Recognized in

OCI-Effective

Portion

 

 

Location of

Gain or (Loss)

Reclassified

from OCI into

Income-Effective

Portion

 

Gain or (Loss)

Reclassified

from OCI into

Income-Effective

Portion

 

 

Location of

Gain or (Loss)

Recognized-

Ineffective Portion

and Amount Excluded from

Effectiveness Testing

 

Gain or (Loss)

Recognized-

Ineffective Portion

and Amount

Excluded from

Effectiveness

Testing (a)

 

Foreign exchange contracts

 

$

(421

)

 

Product revenues

 

$

(2,865

)

 

Interest and other income (expense), net

 

$

75

 

 

 

 

 

 

 

Cost of revenues

 

 

532

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

1,080

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

415

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

172

 

 

 

 

 

 

 

Total

 

$

(421

)

 

 

 

$

(666

)

 

 

 

$

75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

March 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

2,957

 

 

Product revenues

 

$

627

 

 

Interest and other income (expense), net

 

$

 

 

 

 

 

 

 

Cost of revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

178

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

(103

)

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

12

 

 

 

 

 

 

 

Total

 

$

2,957

 

 

 

 

$

714

 

 

 

 

$

 

_______________________

(a)

For both the three months ended March 31, 2014 and 2013, there were no gains or losses recognized in income due to ineffectiveness.                                   

Stockholders' Equity (Tables)
Changes in Accumulated Other Comprehensive Income (Loss) by Component

The following table summarizes the changes in accumulated other comprehensive income, net of tax, by component for the three months ended March 31, 2014 (in thousands). The tax effects were not shown separately, as the impacts were not material.

 

Three Months Ended March 31, 2014

 

Unrealized

Gains and

Losses on

Cash Flow

Hedges

 

 

Unrealized Gains

and Losses on

Available-for-

Sale Securities

 

 

Foreign Currency

Translation

 

 

Total

 

Balance as of December 31, 2013

 

$

80

 

 

$

73

 

 

$

4,219

 

 

$

4,372

 

Other comprehensive income (loss) before reclassifications

 

 

(421

)

 

 

(7

)

 

 

(1,203

)

 

 

(1,631

)

Amounts reclassified from accumulated

     other comprehensive income (a)

 

 

666

 

 

 

(1

)

 

 

 

 

 

665

 

Net current-period other comprehensive income (loss)

 

 

245

 

 

 

(8

)

 

 

(1,203

)

 

 

(966

)

Balance as of March 31, 2014

 

$

325

 

 

$

65

 

 

$

3,016

 

 

$

3,406

 

_____________

 

(a)

See Note 12 of Notes to Condensed Consolidated Financial Statements for details of gains and losses, net of taxes, reclassified out of accumulated other comprehensive income into net income related to cash flow hedges and each line item of net income affected by the reclassification. Gains and losses related to available-for-sale securities were reclassified into “Other income (expense)” in the condensed consolidated statement of operations for the three months ended March 31, 2014, net of taxes.

 

Stock-Based Compensation (Tables)

The following table summarizes stock-based compensation expense recorded for the three months ended March 31, 2014 and 2013 and its allocation within the condensed consolidated statements of operations (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Cost of sales - product

$

640

 

 

$

861

 

Cost of sales - service

 

961

 

 

 

1,476

 

Stock-based compensation expense included in cost of sales

 

1,601

 

 

 

2,337

 

 

 

 

 

 

 

 

 

Sales and marketing

 

391

 

 

 

6,636

 

Research and development

 

1,042

 

 

 

4,721

 

General and administrative

 

2,613

 

 

 

4,077

 

Stock-based compensation expense included in operating

     expenses

 

4,046

 

 

 

15,434

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases

 

5,647

 

 

 

17,771

 

Tax benefit

 

985

 

 

 

3,895

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases, net of tax

$

4,662

 

 

$

13,876

 

 

The fair value of each employee stock purchase right grant is estimated on the date of grant using the Black-Scholes option valuation model and is recognized as expense using the graded vesting method using the following assumptions:

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Expected volatility

32.30-42.11%

 

 

44.76-50.55%

 

Risk-free interest rate

0.07-0.30%

 

 

0.11-0.27%

 

Expected dividends

 

0.0%

 

 

 

0.0%

 

Expected life (yrs)

0.5-2.0

 

 

0.5-2.0

 

 

Net Income (Loss) Per Share (Tables)
Reconciliation of Numerator and Denominator of Basic and Diluted Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share for the periods presented (in thousands, except for per-share amounts):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

Net income (loss) from continuing operations

$

(3,991

)

 

$

2,117

 

Gain from sale of discontinued operations, net of taxes

 

 

 

 

459

 

Net income (loss)

$

(3,991

)

 

$

2,576

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

136,795

 

 

 

176,079

 

Effect of dilutive potential common shares

 

 

 

 

3,061

 

Weighted average shares outstanding, diluted

 

136,795

 

 

 

179,140

 

 

 

 

 

 

 

 

 

Basic net income (loss) per share

 

 

 

 

 

 

 

Net income (loss) per share from continuing operations

$

(0.03

)

 

$

0.01

 

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

$

(0.03

)

 

$

0.01

 

 

 

 

 

 

 

 

 

Diluted net income (loss) per share

 

 

 

 

 

 

 

Net income (loss) per share from continuing operations

$

(0.03

)

 

$

0.01

 

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

$

(0.03

)

 

$

0.01

 

 

 

 

 

 

 

 

 

Antidilutive employee stock-based awards, excluded

 

5,855

 

 

 

1,717

 

 

Business Segment Information (Tables)

Financial information for each reportable geographical segment as of March 31, 2014 and December 31, 2013 and for the three months ended March 31, 2014 and 2013, based on the Company’s internal management reporting system and as utilized by the Company’s Chief Executive Officer who is its Chief Operating Decision Maker (“CODM”), is as follows (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

For the three months ended March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

163,070

 

 

$

89,036

 

 

$

76,418

 

 

$

328,524

 

% of total revenue

 

50

%

 

 

27

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,973

 

 

 

37,666

 

 

 

31,655

 

 

 

139,294

 

% of segment revenue

 

43

%

 

 

42

%

 

 

41

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended March 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

170,981

 

 

$

89,092

 

 

$

78,679

 

 

$

338,752

 

% of total revenue

 

51

%

 

 

26

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,229

 

 

 

37,560

 

 

 

30,845

 

 

 

137,634

 

% of segment revenue

 

40

%

 

 

42

%

 

 

39

%

 

 

41

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of March 31, 2014: Gross accounts receivable

$

91,399

 

 

$

71,734

 

 

$

60,917

 

 

$

224,050

 

% of total gross accounts receivable

 

41

%

 

 

32

%

 

 

27

%

 

 

100

%

As of December 31, 2013: Gross accounts receivable

 

86,243

 

 

 

71,970

 

 

 

66,921

 

 

 

225,134

 

% of total gross accounts receivable

 

38

%

 

 

32

%

 

 

30

%

 

 

100

%

 

The reconciliation of segment information to Polycom consolidated totals is as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Segment contribution margin

$

139,294

 

 

$

137,634

 

Corporate and unallocated costs

 

(106,600

)

 

 

(107,705

)

Stock-based compensation

 

(5,647

)

 

 

(17,771

)

Effect of stock-based compensation cost on warranty expense

 

(129

)

 

 

(157

)

Transaction-related costs

 

(156

)

 

 

(3,323

)

Amortization of purchased intangibles

 

(3,333

)

 

 

(3,750

)

Restructuring costs

 

(30,343

)

 

 

(5,423

)

Interest and other income (expense), net

 

(695

)

 

 

(759

)

Loss from continuing operations before benefit from income taxes

$

(7,609

)

 

$

(1,254

)

 

 

March 31,

2014

 

 

December 31,

2013

 

Gross accounts receivables

$

224,050

 

 

$

225,134

 

Returns and related reserves

 

(37,006

)

 

 

(38,938

)

Allowance for doubtful accounts

 

(2,805

)

 

 

(2,827

)

Total trade receivables, net

$

184,239

 

 

$

183,369

 

 

The following table summarizes the Company’s revenues by groups of similar products and services as follows (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Revenues:

 

 

 

 

 

 

 

UC group systems

$

213,372

 

 

$

232,426

 

UC personal devices

 

56,474

 

 

 

49,246

 

UC platform

 

58,678

 

 

 

57,080

 

Total

$

328,524

 

 

$

338,752

 

 

Income Taxes (Tables)
Income Tax Expense (Benefit) from Continuing Operations and Effective Tax Rates

The following table presents the income tax benefit from continuing operations and the effective tax rates (in thousands):

 

 

Three Months Ended

 

 

March 31,

2014

 

 

March 31,

2013

 

Income tax benefit from continuing operations

$

(3,618

)

 

$

(3,371

)

Effective tax rate

 

47.5

%

 

 

268.8

%

 

Revision to the Condensed Consolidated Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Change In Accounting Estimate [Line Items]
 
 
Amortization of discounts and premiums on investments, net
$ 442 
$ 386 
Net cash provided by operating activities
19,094 
49,400 
Purchases of investments
(90,663)
(55,754)
Net cash provided by investing activities
(37,121)
1,058 
As Previously Reported
 
 
Change In Accounting Estimate [Line Items]
 
 
Amortization of discounts and premiums on investments, net
 
Net cash provided by operating activities
 
49,014 
Purchases of investments
 
(55,368)
Net cash provided by investing activities
 
1,444 
Adjustment
 
 
Change In Accounting Estimate [Line Items]
 
 
Amortization of discounts and premiums on investments, net
 
386 
Net cash provided by operating activities
 
386 
Purchases of investments
 
(386)
Net cash provided by investing activities
 
$ (386)
Discontinued Operations - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended
Dec. 4, 2012
Mar. 31, 2013
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
Gain from sale of discontinued operations, net of taxes
$ 35,400,000 
$ 459,000 
Mobile Devices Holdings LLC
 
 
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
Cash proceeds received
50,700,000 
 
Mobile Devices Holdings LLC |
Maximum
 
 
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
Additional cash consideration payable over the next three years subject to certain conditions, including meeting certain agreed-upon EBITDA-based milestones
 
$ 37,500,000 
Business Combination - Additional Information (Detail) (USD $)
3 Months Ended
Sep. 30, 2013
Mar. 31, 2013
Business Combination Separately Recognized Transactions [Line Items]
 
 
Net cash paid in acquisitions
 
$ 8,350,000 
Cash received from net working capital adjustment
$ 400,000 
 
Accounts Receivable Financing - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Accounts Notes And Loans Receivable [Line Items]
 
 
 
Amount of total outstanding receivables transferred
$ 32.0 
$ 24.9 
 
Amount due from the financing company
19.7 
 
22.9 
Fees incurred pursuant to the factoring agreement
0.5 
0.3 
 
Accounts Receivable
 
 
 
Accounts Notes And Loans Receivable [Line Items]
 
 
 
Amount of total outstanding receivables transferred
31.1 
22.3 
 
Amount due from the financing company
$ 19.2 
 
$ 21.6 
Schedule of Goodwill by Segment (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Goodwill [Line Items]
 
Beginning Balance
$ 559,460 
Foreign currency translation
(226)
Ending Balance
559,234 
Americas
 
Goodwill [Line Items]
 
Beginning Balance
308,159 
Foreign currency translation
   
Ending Balance
308,159 
EMEA
 
Goodwill [Line Items]
 
Beginning Balance
101,882 
Foreign currency translation
   
Ending Balance
101,882 
APAC
 
Goodwill [Line Items]
 
Beginning Balance
149,419 
Foreign currency translation
(226)
Ending Balance
$ 149,193 
Details of Purchased Intangible Assets by Major Class (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
$ 170,365 
$ 170,365 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(137,177)
(133,825)
Finite Lived Intangible Assets, Net Value
33,188 
36,540 
Total intangible assets, Gross Value
171,283 
171,283 
Total intangible assets, Accumulated Amortization and Impairment
(137,177)
(133,825)
Total intangible assets, Net Value
34,106 
37,458 
Indefinite lived trade name
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Indefinite Lived Intangible Assets, Gross Value
918 
918 
Indefinite Lived Intangible Assets, Accumulated Amortization and Impairment
 
Indefinite Lived Intangible Assets, Net Value
918 
918 
Core and developed technology
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
81,178 
81,178 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(77,793)
(76,952)
Finite Lived Intangible Assets, Net Value
3,385 
4,226 
Customer and partner relationships
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
79,525 
79,525 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(51,248)
(48,941)
Finite Lived Intangible Assets, Net Value
28,277 
30,584 
Non-compete agreement
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
1,800 
1,800 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(650)
(500)
Finite Lived Intangible Assets, Net Value
1,150 
1,300 
Trade name
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
3,400 
3,400 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(3,124)
(3,089)
Finite Lived Intangible Assets, Net Value
276 
311 
Other
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
4,462 
4,462 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(4,362)
(4,343)
Finite Lived Intangible Assets, Net Value
100 
119 
Software development costs for products to be sold
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
3,474 
2,365 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(484)
(196)
Finite Lived Intangible Assets, Net Value
$ 2,990 
$ 2,169 
Goodwill, Purchased Intangibles, and Software Development Costs - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Software development costs
 
Indefinite Lived Intangible Assets And Internally Developed Software [Line Items]
 
Capitalized software development costs
$ 1.1 
Computer Software, Intangible Asset
 
Indefinite Lived Intangible Assets And Internally Developed Software [Line Items]
 
Intangible assets with finite lives, estimated economic lives, years
3 years 
Indefinite life trade name
 
Indefinite Lived Intangible Assets And Internally Developed Software [Line Items]
 
Purchased indefinite lived intangibles
$ 0.9 
Summary of Amortization Expenses (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Acquired Finite Lived Intangible Assets [Line Items]
 
 
Amortization of purchased intangibles in revenues
$ 19 
$ 18 
Amortization of purchased intangibles in cost of product revenues
841 
1,248 
Amortization of purchased intangibles
2,492 
2,502 
Total amortization expenses of purchased intangibles
$ 3,352 
$ 3,768 
Estimated Future Amortization Expense of Purchased Intangible Assets (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Finite Lived Intangible Assets [Line Items]
 
 
Remainder of 2014
$ 9,539 
 
2015
10,495 
 
2016
8,484 
 
2017
4,670 
 
2018
   
 
Total
$ 33,188 
$ 36,540 
Restructuring Costs - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Restructuring Cost And Reserve [Line Items]
 
 
Restructuring costs
$ 30,343 
$ 5,423 
Additions to the reserve
30,343 
 
Global workforce elimination percentage under restructuring plan
6.00% 
 
February 2014 Restructuring
 
 
Restructuring Cost And Reserve [Line Items]
 
 
Additions to the reserve
$ 29,900 
 
Summary of Activity of Restructuring Reserves (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Restructuring Cost And Reserve [Line Items]
 
Beginning balance
$ 34,929 
Additions to the reserve
30,343 
Non-cash write-offs
(3,359)
Cash payments and other usage
(11,732)
Ending balance
50,181 
Severance / Other
 
Restructuring Cost And Reserve [Line Items]
 
Beginning balance
1,143 
Additions to the reserve
10,557 
Non-cash write-offs
   
Cash payments and other usage
(8,264)
Ending balance
3,436 
Facilities
 
Restructuring Cost And Reserve [Line Items]
 
Beginning balance
33,786 
Additions to the reserve
19,786 
Non-cash write-offs
(3,359)
Cash payments and other usage
(3,468)
Ending balance
$ 46,745 
Schedule of Inventories (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Inventory [Line Items]
 
 
Raw materials
$ 3,210 
$ 2,740 
Work in process
1,002 
840 
Finished goods
99,068 
99,729 
Inventories
$ 103,280 
$ 103,309 
Prepaid Expenses and Other Current Assets (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Schedule Of Prepaid Expenses And Other Current Assets [Line Items]
 
 
Non-trade receivables
$ 9,245 
$ 9,251 
Prepaid expenses
40,422 
31,164 
Derivative assets
5,448 
6,748 
Other current assets
3,867 
3,189 
Prepaid And Other Current Assets, Total
$ 58,982 
$ 50,352 
Schedule of Deferred Revenues (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
$ 172,703 
$ 172,408 
Long-term deferred revenue
86,078 
87,467 
Software Service, Support and Maintenance Arrangement
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
171,041 
170,701 
Long-term deferred revenue
82,003 
83,092 
Software License Arrangement
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
1,550 
1,400 
Long-term deferred revenue
4,057 
4,375 
Product
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
112 
307 
Long-term deferred revenue
$ 18 
 
Schedule of Other Accrued Liabilities (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Mar. 31, 2013
Dec. 31, 2012
Other Accrued Liabilities [Line Items]
 
 
 
 
Accrued expenses
$ 20,658 
$ 22,515 
 
 
Accrued co-op expenses
4,159 
4,629 
 
 
Restructuring reserves
20,060 
11,238 
 
 
Warranty obligations
10,006 
9,475 
9,715 
10,475 
Derivative liabilities
6,172 
6,780 
 
 
Employee stock purchase plan withholdings
4,132 
10,883 
 
 
Other accrued liabilities
11,654 
12,224 
 
 
Total accrued and other current liabilities
$ 76,841 
$ 77,744 
 
 
Changes in Warranty Obligation (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Product Warranty Liability [Line Items]
 
 
Beginning Balance
$ 9,475 
$ 10,475 
Accruals for warranties issued during the period
4,165 
3,619 
Actual charges against warranty reserve during the period
(3,634)
(4,379)
Ending Balance
$ 10,006 
$ 9,715 
Changes in Deferred Services Revenue (Detail) (Services Revenue, USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Services Revenue
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Beginning Balance
$ 253,793 
$ 241,773 
Additions to deferred services revenue
85,894 
87,752 
Amortization of deferred services revenue
(86,643)
(83,506)
Ending Balance
$ 253,044 
$ 246,019 
Debt - Additional Information (Detail) (USD $)
0 Months Ended 3 Months Ended
Sep. 13, 2013
Mar. 31, 2014
Dec. 31, 2013
Debt Instrument [Line Items]
 
 
 
Term loan
$ 250,000,000 
 
 
Maturity date of term loan
Sep. 13, 2018 
 
 
Term loan quarterly installments
1,600,000 
 
 
Term loan payable period
Interest is due and payable in arrears quarterly for loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of loans bearing interest at the reserve adjusted LIBOR rate. 
 
 
Debt issuance costs
 
2,700,000 
 
Default interest rate applicable for any overdue principal
 
2.00% 
 
Default interest rate for base rate loans for any other overdue amounts
 
2.00% 
 
Weighted average interest rate
 
1.97% 
 
Accrued interest on Term loan
 
200,000 
 
Term loan, current
 
6,250,000 
6,250,000 
Long-term debt
 
$ 240,625,000 
$ 242,188,000 
Base Rate |
Minimum
 
 
 
Debt Instrument [Line Items]
 
 
 
Term loan interest rate, applicable margin
0.50% 
 
 
Base Rate |
Maximum
 
 
 
Debt Instrument [Line Items]
 
 
 
Term loan interest rate, applicable margin
1.00% 
 
 
LIBOR rate plus |
Minimum
 
 
 
Debt Instrument [Line Items]
 
 
 
Term loan interest rate, applicable margin
1.50% 
 
 
LIBOR rate plus |
Maximum
 
 
 
Debt Instrument [Line Items]
 
 
 
Term loan interest rate, applicable margin
2.00% 
 
 
Interest Expenses Recognized (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Debt Instrument [Line Items]
 
 
Contractual interest expense
$ 1,229 
    
Amortization of debt issuance costs
134 
   
Total
$ 1,363 
    
Investments and Fair Value Measurements - Additional Information (Detail) (USD $)
3 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
 
 
Cash and cash equivalents
$ 380,214,000 
$ 392,629,000 
Long-term investments, contractual maturity period, low, years
1 year 
 
Long-term investments, contractual maturity period, high, years
2 years 
 
Cost of investment in private company
2,000,000 
2,000,000 
U.S. Treasury and other government agencies percentage of fixed income available-for-sale securities
52.00% 
 
Corporate bonds percentage of fixed income available-for-sale securities
24.00% 
 
Commercial paper percentage of available-for-sale securities
17.00% 
 
Non-U.S. Government securities percentage of available-for-sale securities
6.00% 
 
Money market funds percentage of available-for-sale securities
1.00% 
 
Cash equivalents included in available-for-sale securities
18,200,000 
 
Investment Maturity Period Maximum
3 months 
 
United States
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
 
 
Cash equivalents and investments
212,500,000 
 
Foreign Subsidiaries Outside of United States
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
 
 
Cash equivalents and investments
$ 383,400,000 
 
Short-Term and Long-Term Investments in Debt Securities (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Schedule Of Available For Sale Securities [Line Items]
 
 
Short-term investments
$ 149,890 
$ 134,684 
Long-term investments
65,835 
56,372 
Short-term Investments
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
149,815 
134,634 
Unrealized Gains
83 
57 
Unrealized Losses
(8)
(7)
Short-term investments
149,890 
134,684 
Short-term Investments |
US Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
27,221 
19,792 
Unrealized Gains
18 
Unrealized Losses
   
   
Short-term investments
27,239 
19,801 
Short-term Investments |
US Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
46,971 
38,388 
Unrealized Gains
25 
16 
Unrealized Losses
(3)
(3)
Short-term investments
46,993 
38,401 
Short-term Investments |
Non U S Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
12,879 
13,734 
Unrealized Gains
10 
10 
Unrealized Losses
   
   
Short-term investments
12,889 
13,744 
Short-term Investments |
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
62,744 
62,720 
Unrealized Gains
30 
22 
Unrealized Losses
(5)
(4)
Short-term investments
62,769 
62,738 
Long Term Investments
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
65,844 
56,336 
Unrealized Gains
24 
39 
Unrealized Losses
(33)
(3)
Long-term investments
65,835 
56,372 
Long Term Investments |
US Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
19,174 
12,252 
Unrealized Gains
Unrealized Losses
(4)
   
Long-term investments
19,178 
12,260 
Long Term Investments |
US Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
26,539 
30,627 
Unrealized Gains
12 
Unrealized Losses
(13)
(3)
Long-term investments
26,535 
30,636 
Long Term Investments |
Non U S Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
 
2,305 
Unrealized Gains
 
Unrealized Losses
 
   
Long-term investments
 
2,309 
Long Term Investments |
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
20,131 
11,152 
Unrealized Gains
15 
Unrealized Losses
(16)
   
Long-term investments
$ 20,122 
$ 11,167 
Schedule of Investment in Unrealized Loss Position (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
$ 54,348 
$ 15,370 
Gross Unrealized Losses, Less than 12 Months
(41)
(9)
Fair Value, 12 Months or Greater
   
1,504 
Gross Unrealized Losses, 12 Months or Greater
   
(1)
Total Fair Value
54,348 
16,874 
Total Gross Unrealized Losses
(41)
(10)
U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
9,067 
 
Gross Unrealized Losses, Less than 12 Months
(4)
 
Fair Value, 12 Months or Greater
   
 
Gross Unrealized Losses, 12 Months or Greater
   
 
Total Fair Value
9,067 
 
Total Gross Unrealized Losses
(4)
 
U.S.Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
20,114 
5,533 
Gross Unrealized Losses, Less than 12 Months
(16)
(6)
Fair Value, 12 Months or Greater
   
   
Gross Unrealized Losses, 12 Months or Greater
   
   
Total Fair Value
20,114 
5,533 
Total Gross Unrealized Losses
(16)
(6)
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
25,167 
9,837 
Gross Unrealized Losses, Less than 12 Months
(21)
(3)
Fair Value, 12 Months or Greater
   
1,504 
Gross Unrealized Losses, 12 Months or Greater
   
(1)
Total Fair Value
25,167 
11,341 
Total Gross Unrealized Losses
$ (21)
$ (4)
Schedule of Fair Value of Marketable Securities and Foreign Currency Contracts (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
$ 233,916 1
$ 211,151 1
Foreign currency forward contracts, Assets
5,448 2
6,748 2
Foreign currency forward contracts, Liabilities
6,172 3
6,780 3
Quoted Prices in Active Markets for Identical Assets, Level 1
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
3,507 1
17,596 1
Foreign currency forward contracts, Assets
   2
 
Foreign currency forward contracts, Liabilities
   3
 
Significant Other Observable Inputs, Level 2
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
230,409 1
193,555 1
Foreign currency forward contracts, Assets
5,448 2
6,748 2
Foreign currency forward contracts, Liabilities
$ 6,172 3
$ 6,780 3
Notional Position by Currency of Outstanding Non-designated Hedges (Detail) (Not Designated as Hedging Instrument)
In Thousands, unless otherwise specified
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Brazilian Real
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Brazilian Real
BRL
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
CNY
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Euro
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Euro
EUR (€)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
ILS
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Japanese Yen
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Japanese Yen
JPY (¥)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Mexican Peso
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Mexican Peso
MXN ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Euro
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Euro
EUR (€)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
ILS
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Brazilian Real
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Brazilian Real
BRL
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Chinese Yuan
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Chinese Yuan
CNY
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Euro
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Euro
EUR (€)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Israeli Shekel
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Israeli Shekel
ILS
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Japanese Yen
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Japanese Yen
JPY (¥)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Mexican Peso
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Mexican Peso
MXN ($)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
Euro
USD ($)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
Euro
EUR (€)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Derivative [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notional amount of foreign currency
$ 2,298 
 5,200 
$ 7,581 
 46,376 
$ 36,444 
€ 26,445 
$ 22,484 
£ 13,459 
$ 6,463 
 22,544 
$ 4,269 
¥ 440,575 
$ 948 
$ 12,359 
$ 16,037 
€ 12,308 
$ 12,693 
£ 8,366 
$ 11,752 
 43,549 
$ 4,033 
 9,374 
$ 6,380 
 39,267 
$ 72,958 
€ 52,904 
$ 12,857 
£ 7,712 
$ 16,399 
 57,236 
$ 8,290 
¥ 851,223 
$ 1,894 
$ 24,961 
$ 30,843 
€ 23,600 
$ 26,037 
£ 17,031 
Effect of Non-Designated Hedges in Condensed Consolidated Statements of Operations (Detail) (Not Designated as Hedging Instrument, Foreign exchange contract, Interest and other income (expense), net, USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Not Designated as Hedging Instrument |
Foreign exchange contract |
Interest and other income (expense), net
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Amount of Loss Recognized in Income on Derivative
$ 334 
$ 2,333 
Foreign Currency Derivatives - Additional Information (Detail)
3 Months Ended
Mar. 31, 2014
Derivative [Line Items]
 
Maximum duration of foreign exchange forward contracts designated as cash flow hedges
13 months 
Notional Position by Currency of Outstanding Cash Flow Hedges (Detail) (Cash Flow Hedging)
In Thousands, unless otherwise specified
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
CNY
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Euro
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Euro
EUR (€)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
USD ($)
Mar. 31, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
ILS
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Chinese Yuan
CNY
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Euro
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Euro
EUR (€)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
USD ($)
Mar. 31, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
ILS
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Euro
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
Euro
EUR (€)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
USD ($)
Mar. 31, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
Euro
USD ($)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
Euro
EUR (€)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Mar. 31, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Derivative [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notional amount of foreign currency
$ 16,367 
 101,324 
$ 12,127 
€ 8,800 
$ 15,792 
£ 9,500 
$ 5,468 
 19,100 
    
$ 20,526 
€ 15,392 
$ 19,868 
£ 12,634 
$ 15,878 
 56,951 
$ 40,240 
€ 29,200 
$ 23,439 
£ 14,100 
$ 42,200 
€ 31,500 
$ 12,884 
£ 8,069 
Effect of Derivative Instruments Designated as Cash Flow Hedges in Condensed Consolidated Statements of Operations (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Derivative Instruments Gain Loss [Line Items]
 
 
Foreign exchange contracts, Gain or (loss) recognized in OCI-effective portion, total
$ (421)
$ 2,957 
Gain or (loss) reclassified from OCI into income- effective portion, total
(666)
714 
Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness Testing (a)
75 1
   1
Product revenues
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
(2,865)
627 
Cost of revenues
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
532 
 
Sales and marketing
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
1,080 
178 
Research and development
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
415 
(103)
General and administrative
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
172 
12 
Interest and other income (expense), net
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness Testing (a)
75 1
   1
Foreign exchange contract
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
Foreign exchange contracts, Gain or (loss) recognized in OCI-effective portion, total
$ (421)
$ 2,957 
Derivative Instruments Measured at Gross Fair Value as Reflected in Condensed Consolidated Balance Sheets (Detail) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Derivatives Fair Value [Line Items]
 
 
Derivative assets
$ 5,448 
$ 6,748 
Derivative liabilities
6,172 
6,780 
Designated as Hedge Instruments
 
 
Derivatives Fair Value [Line Items]
 
 
Derivative assets
2,303 1
4,457 1
Derivative liabilities
1,854 2
4,235 2
Not Designated as Hedging Instrument
 
 
Derivatives Fair Value [Line Items]
 
 
Derivative assets
3,145 1
2,291 1
Derivative liabilities
$ 4,318 2
$ 2,545 2
Offsetting of Derivative Assets (Detail) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Foreign exchange contract
 
 
Derivative [Line Items]
 
 
Derivative assets
$ 5,448 
$ 6,748 
Gross Amounts Offset in the Statements of Financial Position
   
   
Net Amounts Of Assets Presented In the Statements of Financial Position
5,448 
6,748 
Gross Amounts Not Offset in the Statements of Financial Position, Financial Instruments
(4,493)
(5,643)
Gross Amounts Not Offset in the Statements of Financial Position, Cash Collateral Pledged
   
   
Net Amount
$ 955 
$ 1,105 
Offsetting of Derivative Liabilities (Detail) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Foreign exchange contract
 
 
Derivative [Line Items]
 
 
Derivative liabilities
$ 6,172 
$ 6,780 
Gross Amounts Offset in the Statements of Financial Position
   
   
Net Amounts Of Liabilities Presented In the Statements of Financial Position
6,172 
6,780 
Gross Amounts Not Offset in the Statements of Financial Position, Financial Instruments
(4,493)
(5,643)
Gross Amounts Not Offset in the Statements of Financial Position, Cash Collateral Pledged
   
   
Net Amount
$ 1,679 
$ 1,137 
Stockholders' Equity - Share Repurchase Programs - Additional Information (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
1 Months Ended 3 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended
Oct. 30, 2013
Dec. 31, 2013
Accelerated Share Repurchase Agreements
Dec. 5, 2013
Accelerated Share Repurchase Agreements
Mar. 31, 2013
Stock Repurchase Program
Sep. 13, 2013
Tender Offer
Oct. 30, 2013
Tender Offer
Dec. 31, 2013
Tender Offer
Accelerated Share Repurchase Agreements
Sep. 13, 2013
Return Of Capital Program
Sep. 13, 2013
Return Of Capital Program
Fund program Term loan
Sep. 13, 2013
Return Of Capital Program
Fund program, cash
Share Repurchases Program [Line Items]
 
 
 
 
 
 
 
 
 
 
Purchase of common stock, shares
27.4 
 
 
3.4 
 
 
8.0 
 
 
 
Purchase of common stock, value
 
 
 
$ 34.2 
 
 
 
 
 
 
Shares repurchase authorized amount
 
 
 
 
400.0 
 
114.6 
400.0 
250.0 
150.0 
Percentage of outstanding common stock repurchase
 
 
 
 
 
 
 
20.00% 
 
 
Dutch Auction tender offer, amount
 
 
 
 
250.0 
 
 
 
 
 
Cost of shares repurchased
 
 
 
 
$ 10.40 
 
 
 
 
 
Tender Offer expiration date
 
 
 
 
Oct. 30, 2013 
 
 
 
 
 
Shares repurchase program, shares repurchased value
 
 
86.7 
 
 
285.4 
 
 
 
 
Share repurchase program, remaining shares to be repurchased value
 
$ 27.9 
 
 
 
 
 
 
 
 
Changes in Accumulated Other Comprehensive Income (Loss) by Component (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
$ 4,372 
 
Other comprehensive income before reclassifications
(1,631)
 
Amounts reclassified from accumulated other comprehensive income
665 1
 
Net current-period other comprehensive income
(966)
2,361 
Accumulated Other Comprehensive Income (loss) , Ending balance
3,406 
 
Unrealized Gains and Losses on Cash Flow Hedges
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
80 
 
Other comprehensive income before reclassifications
(421)
 
Amounts reclassified from accumulated other comprehensive income
666 1
 
Net current-period other comprehensive income
245 
 
Accumulated Other Comprehensive Income (loss) , Ending balance
325 
 
Unrealized Gains and Losses on Available-for-Sale Securities
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
73 
 
Other comprehensive income before reclassifications
(7)
 
Amounts reclassified from accumulated other comprehensive income
(1)1
 
Net current-period other comprehensive income
(8)
 
Accumulated Other Comprehensive Income (loss) , Ending balance
65 
 
Foreign Currency Translation
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
4,219 
 
Other comprehensive income before reclassifications
(1,203)
 
Net current-period other comprehensive income
(1,203)
 
Accumulated Other Comprehensive Income (loss) , Ending balance
$ 3,016 
 
Summary and Allocation of Stock-Based Compensation Expense (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
$ 5,647 
$ 17,771 
Tax benefit
985 
3,895 
Stock-based compensation expense related to employee equity awards and employee stock purchases, net of tax
4,662 
13,876 
Cost of sales - product
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
640 
861 
Cost of sales - service
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
961 
1,476 
Cost of revenues
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
1,601 
2,337 
Sales and marketing
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
391 
6,636 
Research and development
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
1,042 
4,721 
General and administrative
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
2,613 
4,077 
Operating Expenses
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
Stock-based compensation expense
$ 4,046 
$ 15,434 
Stock-Based Compensation - Performance Shares and Restricted Stock Units - Additional Information (Detail) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Performance Shares
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
450,580 
1,217,185 
Weighted average estimated fair value of share granted
$ 13.87 
$ 8.76 
Number of performance periods
3 years 
 
Restricted Stock Units (RSUs)
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
2,582,618 
2,299,772 
Weighted average estimated fair value of share granted
$ 12.97 
$ 9.38 
Restricted Stock Units (RSUs) |
Non Employee Directors
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
Stock-Based Compensation - Stock Options and Employee Stock Purchase Plan - Additional Information (Detail) (Employee Stock Purchase Plan)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Employee Stock Purchase Plan
 
 
Stock Option And Employee Stock Purchase Plan [Line Items]
 
 
Number of shares purchased
1,696,177 
1,634,299 
Number of shares approved and available under the Employee Stock Purchase Plan
3,562,959 
 
Stock-Based Compensation - Valuation Assumptions - Additional Information (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Effect of change in forfeiture rate decreased stock compensation expense
$ 1.8 
 
Net loss decreased due to cumulative effect of changes in forfeiture rates on all unvested awards
1.4 
 
Loss per share decreased due to cumulative effect of changes in forfeiture rates on all unvested awards
$ 0.01 
 
Actual forfeitures of awards granted to former officers
$ 2.1 
 
Employee Stock Purchase Plan
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Offering period
2 years 
2 years 
Employee Stock Purchase Plan |
Minimum
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Weighted average estimated fair value of share granted
$ 2.82 
$ 2.93 
Employee Stock Purchase Plan |
Maximum
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Weighted average estimated fair value of share granted
$ 4.48 
$ 4.57 
Nonqualified Stock Option Plan And Employee Stock Purchase |
Historical Volatility
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Blended volatility
50.00% 
 
Nonqualified Stock Option Plan And Employee Stock Purchase |
Implied Volatility
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Blended volatility
50.00% 
 
Significant Assumptions Used to Estimate Fair Value of Employee Stock Purchase Plan (Detail) (Employee Stock Purchase Plan)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Expected dividends
0.00% 
0.00% 
Minimum
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Expected volatility
32.30% 
44.76% 
Risk-free interest rate
0.07% 
0.11% 
Expected life (yrs)
6 months 
6 months 
Maximum
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Expected volatility
42.11% 
50.55% 
Risk-free interest rate
0.30% 
0.27% 
Expected life (yrs)
2 years 
2 years 
Reconciliation of Numerator and Denominator of Basic and Diluted Net Income (Loss) Per Share (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified
1 Months Ended 3 Months Ended
Dec. 4, 2012
Mar. 31, 2014
Mar. 31, 2013
Schedule Of Earnings Per Share Basic And Diluted By Common Class [Line Items]
 
 
 
Net income (loss) from continuing operations
 
$ (3,991)
$ 2,117 
Gain from sale of discontinued operations, net of taxes
35,400 
 
459 
Net income (loss)
 
$ (3,991)
$ 2,576 
Weighted average shares outstanding, basic
 
136,795 
176,079 
Effect of dilutive potential common shares
 
 
3,061 
Weighted average shares outstanding, diluted
 
136,795 
179,140 
Net income (loss) per share from continuing operations
 
$ (0.03)
$ 0.01 
Gain per share from sale of discontinued operations, net of taxes
 
   
   
Basic net income (loss) per share
 
$ (0.03)
$ 0.01 
Net income (loss) per share from continuing operations
 
$ (0.03)
$ 0.01 
Gain per share from sale of discontinued operations, net of taxes
 
   
   
Diluted net income (loss) per share
 
$ (0.03)
$ 0.01 
Antidilutive employee stock-based awards, excluded
 
5,855 
1,717 
Business Segment Information - Additional Information (Detail)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Segment Reporting Information [Line Items]
 
 
Business organized number of geographical theatres (area)
 
Product revenues |
Americas |
Operating Segments
 
 
Segment Reporting Information [Line Items]
 
 
Concentration percentage on one customer
18.00% 
17.00% 
Accounts Receivable |
Americas |
Operating Segments
 
 
Segment Reporting Information [Line Items]
 
 
Concentration percentage on one customer
15.00% 
11.00% 
United States |
Operating Segments
 
 
Segment Reporting Information [Line Items]
 
 
Single customer accounted for more than 10% of gross accounts receivable
Financial Information by Reportable Segment (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Segment Reporting Information [Line Items]
 
 
 
Revenue
$ 328,524 
$ 338,752 
 
% of total revenue
100.00% 
100.00% 
 
Contribution margin
139,294 
137,634 
 
% of segment revenue
42.00% 
41.00% 
 
Gross accounts receivable
224,050 
 
225,134 
% of total gross accounts receivable
100.00% 
 
100.00% 
Americas
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue
163,070 
170,981 
 
% of total revenue
50.00% 
51.00% 
 
Contribution margin
69,973 
69,229 
 
% of segment revenue
43.00% 
40.00% 
 
Gross accounts receivable
91,399 
 
86,243 
% of total gross accounts receivable
41.00% 
 
38.00% 
EMEA
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue
89,036 
89,092 
 
% of total revenue
27.00% 
26.00% 
 
Contribution margin
37,666 
37,560 
 
% of segment revenue
42.00% 
42.00% 
 
Gross accounts receivable
71,734 
 
71,970 
% of total gross accounts receivable
32.00% 
 
32.00% 
APAC
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Revenue
76,418 
78,679 
 
% of total revenue
23.00% 
23.00% 
 
Contribution margin
31,655 
30,845 
 
% of segment revenue
41.00% 
39.00% 
 
Gross accounts receivable
$ 60,917 
 
$ 66,921 
% of total gross accounts receivable
27.00% 
 
30.00% 
Reconciliation of Segment Information to Consolidated Totals (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Segment Reporting Information [Line Items]
 
 
 
Segment contribution margin
$ 139,294 
$ 137,634 
 
Corporate and unallocated costs
(106,600)
(107,705)
 
Stock-based compensation
(5,647)
(17,771)
 
Effect of stock-based compensation cost on warranty expense
(129)
(157)
 
Transaction-related costs
(156)
(3,323)
 
Amortization of purchased intangibles
(3,333)
(3,750)
 
Restructuring costs
(30,343)
(5,423)
 
Interest and other income (expense), net
(695)
(759)
 
Loss from continuing operations before benefit from income taxes
(7,609)
(1,254)
 
Gross accounts receivable
224,050 
 
225,134 
Returns and related reserves
(37,006)
 
(38,938)
Allowance for doubtful accounts
(2,805)
 
(2,827)
Total trade receivables, net
$ 184,239 
 
$ 183,369 
Revenues by Groups of Similar Products and Services (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Entity Wide Information Revenue From External Customer [Line Items]
 
 
Net Revenues
$ 328,524 
$ 338,752 
UC Group Systems |
Operating Segments
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
Net Revenues
213,372 
232,426 
UC Personal Devices |
Operating Segments
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
Net Revenues
56,474 
49,246 
UC Platform |
Operating Segments
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
Net Revenues
$ 58,678 
$ 57,080 
Income Tax Expense (Benefit) from Continuing Operations and Effective Tax Rates (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Income Taxes [Line Items]
 
 
Income tax benefit from continuing operations
$ (3,618)
$ (3,371)
Effective tax rate
47.50% 
268.80% 
Income Taxes - Additional Information (Detail) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Income Tax Information [Line Items]
 
 
 
Benefit from income taxes
$ (3,618,000)
$ (3,371,000)
 
Effective tax rate
47.50% 
268.80% 
 
U.S federal statutory rate
35.00% 
 
 
Discrete tax benefits realized on disqualifying dispositions of stock
1,300,000 
800,000 
 
Stock-based compensation expense adjustments related to certain terminated employees
900,000 
 
 
Reinstatement of the federal research and development tax credit
 
2,200,000 
 
Unrecognized tax benefits
22,100,000 
 
 
Accrued interest and penalties related to uncertain tax positions
1,500,000 
 
1,500,000 
Anticipated reduction in uncertain tax positions
$ 900,000